{"DataElement":{"publicId":"6780670","version":"1","preferredName":"Personal Medical History Condition CPTAC Codelist Name","preferredDefinition":"Text term(s) used in support of the data collection efforts of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) with the focus on illness or circumstance which requires medical monitoring.","longName":"6780642v1.0:6780651v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6780642","version":"1","preferredName":"Personal Medical History Medical Condition","preferredDefinition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._Any kind of illness or circumstance which requires medical monitoring.","longName":"2431097v1.0:6780640v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"2431097","version":"1","preferredName":"Personal Medical History","preferredDefinition":"an account of all medical events and problems a person has experienced.","longName":"C18772","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF61-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6780640","version":"1","preferredName":"Medical Condition","preferredDefinition":"Any kind of illness or circumstance which requires medical monitoring.","longName":"C156809","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical Condition","conceptCode":"C156809","definition":"Any kind of illness or circumstance which requires medical monitoring.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B1F28E8-F30D-48DA-E053-F662850AB58A","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-12","modifiedBy":"ONEDATA","dateModified":"2019-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B1F28E8-F31E-48DA-E053-F662850AB58A","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-12","modifiedBy":"KNABLEJ","dateModified":"2019-11-10","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  6-12-19 CPTAC Med History form; tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6780651","version":"1","preferredName":"CPTAC Medical Conditions Codelist Name","preferredDefinition":"Terminology used in support of the data collection efforts of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) with the focus on medical conditions._The words or language units by which a thing is known.","longName":"6780651v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Pressure Sore","valueDescription":"Pressure Sore","ValueMeaning":{"publicId":"4395772","version":"1","preferredName":"Pressure Sore","longName":"4395772","preferredDefinition":"Death of tissue due to external pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pressure Sore","conceptCode":"C50706","definition":"Death of tissue due to external pressure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D96F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CD324-D855-33DE-E053-F662850AF940","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Poisoning","valueDescription":"Poisoning","ValueMeaning":{"publicId":"2654073","version":"1","preferredName":"Poisoning","longName":"2654073","preferredDefinition":"A condition or physical state produced by the ingestion, injection or inhalation of, or exposure to a deleterious agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poisoning","conceptCode":"C34933","definition":"Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32BD3B68-2478-4708-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"UMLLOADER_TOBACCO","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CD324-D86A-33DE-E053-F662850AF940","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Pneumoconiosis","valueDescription":"Pneumoconiosis","ValueMeaning":{"publicId":"2559819","version":"1","preferredName":"Pneumoconiosis","longName":"2559819","preferredDefinition":"An occupational lung disorder caused by inhalation of dust particles. It is characterized by bilateral interstitial lung infiltrates. Representative examples include asbestosis, silicosis, anthracosis, and talc pneumoconiosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumoconiosis","conceptCode":"C26861","definition":"An occupational lung disorder caused by inhalation of dust particles. It is characterized by bilateral interstitial lung infiltrates. Representative examples include asbestosis, silicosis, anthracosis, and talc pneumoconiosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6B8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CD324-D875-33DE-E053-F662850AF940","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Plasma Cell Myeloma","valueDescription":"Plasma Cell Myeloma","ValueMeaning":{"publicId":"5581351","version":"1","preferredName":"Plasma Cell Myeloma","longName":"5581351","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B9DD-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CD324-D880-33DE-E053-F662850AF940","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Self-Injury","valueDescription":"Self-Injury","ValueMeaning":{"publicId":"6834698","version":"1","preferredName":"Self-Injury","longName":"6834698","preferredDefinition":"Self-inflicted harm without the intent to die.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Self-Injury","conceptCode":"C118206","definition":"Self-inflicted harm without the intent to die.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBF6348-69FE-7F32-E053-F662850A55D4","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBF6348-6A19-7F32-E053-F662850A55D4","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Treatment-Emergent Adverse Event","valueDescription":"Treatment-Emergent Adverse Event","ValueMeaning":{"publicId":"6834702","version":"1","preferredName":"Treatment-Emergent Adverse Event","longName":"6834702","preferredDefinition":"A situation that emerges during treatment, having been absent pretreatment, or worsens relative to the pretreatment state. (ICH)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment-Emergent Adverse Event","conceptCode":"C142733","definition":"A situation that emerges during treatment, having been absent pretreatment, or worsens relative to the pretreatment state. (ICH)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFB452-A896-7F11-E053-F662850AD667","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFB452-A8B1-7F11-E053-F662850AD667","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Abortion Finding","valueDescription":"Abortion Finding","ValueMeaning":{"publicId":"4395606","version":"1","preferredName":"Abortion Finding","longName":"4395606","preferredDefinition":"Any termination of pregnancy happening before the fetus is able to sustain independent life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abortion Finding","conceptCode":"C35221","definition":"The unintentional or intentional loss of a pregnancy before 22 weeks gestation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB7339A-0805-4109-E040-BB89AD430DAA","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5A62-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Abscess","valueDescription":"Abscess","ValueMeaning":{"publicId":"5296399","version":"1","preferredName":"Abscess","longName":"5296399","preferredDefinition":"An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abscess","conceptCode":"C26686","definition":"An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"355C3F46-93D2-E765-E050-BB89AD431721","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5A6D-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Accidental Injury","valueDescription":"Accidental Injury","ValueMeaning":{"publicId":"6660920","version":"1","preferredName":"Accidental Injury","longName":"6660920","preferredDefinition":"Unintentional trauma to the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accidental Injury","conceptCode":"C35165","definition":"Unintentional trauma to the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830B8ACA-B0DD-5D9D-E053-F662850A2B8C","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5A78-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Acquired Immunodeficiency Syndrome","valueDescription":"Acquired Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3105388","version":"1","preferredName":"Acquired Immunodeficiency Syndrome","longName":"3105388","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88262FC2-CEBC-A44E-E040-BB89AD435306","latestVersionIndicator":"Yes","beginDate":"2010-06-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5A8D-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Seizure Disorder","valueDescription":"Seizure Disorder","ValueMeaning":{"publicId":"4827918","version":"1","preferredName":"Seizure Disorder","longName":"4827918","preferredDefinition":"A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure Disorder","conceptCode":"C3020","definition":"A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F1BB-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8AA5-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Schizophrenia","valueDescription":"Schizophrenia","ValueMeaning":{"publicId":"3165564","version":"1","preferredName":"Schizophrenia","longName":"3165564","preferredDefinition":"A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schizophrenia","conceptCode":"C3362","definition":"A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C0A3-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8AB0-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Rheumatoid Arthritis","valueDescription":"Rheumatoid Arthritis","ValueMeaning":{"publicId":"2570667","version":"1","preferredName":"Rheumatoid Arthritis","longName":"2570667","preferredDefinition":"A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rheumatoid Arthritis","conceptCode":"C2884","definition":"A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E118-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CZECHS","dateModified":"2008-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8ABA-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Rectal Carcinoma","valueDescription":"Rectal Carcinoma","ValueMeaning":{"publicId":"4839991","version":"1","preferredName":"Rectal Carcinoma","longName":"4839991","preferredDefinition":"A malignant epithelial neoplasm that arises from the rectum and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Carcinoma","conceptCode":"C9382","definition":"A malignant epithelial neoplasm that arises from the rectum. The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17181BD7-C47D-F1F7-E050-BB89AD431A04","latestVersionIndicator":"Yes","beginDate":"2015-05-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8AEB-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Rabies","valueDescription":"Rabies","ValueMeaning":{"publicId":"3211407","version":"1","preferredName":"Rabies","longName":"3211407","preferredDefinition":"A life-threatening viral infection caused by the neurotropic Rabies virus. It is transmitted to humans usually from a bite by an infected dog. The initial signs and symptoms include malaise, fever, and headache, followed by the central nervous system manifestations which include abrupt behavioral changes. Paralysis, lethargy, and coma follow the behavioral changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rabies","conceptCode":"C28182","definition":"A life-threatening viral infection caused by the neurotropic Rabies virus. It is transmitted to humans usually from a bite by an infected dog. The initial signs and symptoms include malaise, fever, and headache, followed by the central nervous system manifestations which include abrupt behavioral changes. Paralysis, lethargy, and coma follow the behavioral changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F975-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8AF5-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Pyelonephritis","valueDescription":"Pyelonephritis","ValueMeaning":{"publicId":"2945215","version":"1","preferredName":"Pyelonephritis","longName":"2945215","preferredDefinition":"An acute or chronic inflammatory process affecting the kidney. It is caused by bacteria and in most cases it is the result of a urinary tract infection. Signs and symptoms include fever, chills, flank pain, painful and frequent urination, cloudy or bloody urine, and confusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pyelonephritis","conceptCode":"C34965","definition":"An inflammatory process affecting the kidney. The cause is most often bacterial, but may also be fungal in nature. Signs and symptoms may include fever, chills, flank pain, painful and frequent urination, cloudy or bloody urine, and confusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-441E-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8B00-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Pulmonary Sarcoidosis","valueDescription":"Pulmonary Sarcoidosis","ValueMeaning":{"publicId":"3211403","version":"1","preferredName":"Pulmonary Sarcoidosis","longName":"3211403","preferredDefinition":"Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Sarcoidosis","conceptCode":"C34997","definition":"Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F8ED-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9D15B2-8B0B-381B-E053-F662850A085C","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Uterine Corpus Leiomyoma","valueDescription":"Uterine Corpus Leiomyoma","ValueMeaning":{"publicId":"3651251","version":"1","preferredName":"Uterine Corpus Leiomyoma","longName":"3651251","preferredDefinition":"A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Leiomyoma","conceptCode":"C3434","definition":"A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2F9932D-58ED-5E62-E040-BB89AD437C8B","latestVersionIndicator":"Yes","beginDate":"2013-01-10","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-01-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFCF8C-4BD2-6866-E053-F662850A6631","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Urolithiasis","valueDescription":"Urolithiasis","ValueMeaning":{"publicId":"6834708","version":"1","preferredName":"Urolithiasis","longName":"6834708","preferredDefinition":"Stone(s) within the urinary tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urolithiasis","conceptCode":"C114688","definition":"Stone(s) within the urinary tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFCF8C-4BE0-6866-E053-F662850A6631","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFCF8C-4BF9-6866-E053-F662850A6631","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Urogenital Disease","valueDescription":"Genitourinary System Disorder","ValueMeaning":{"publicId":"6834710","version":"1","preferredName":"Genitourinary System Disorder","longName":"6834710","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the genitourinary system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genitourinary System Disorder","conceptCode":"C156660","definition":"A non-neoplastic or neoplastic disorder that affects the genitourinary system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFCF8C-4C06-6866-E053-F662850A6631","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFCF8C-4C1F-6866-E053-F662850A6631","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Urinary Tract Infection","valueDescription":"Urinary Tract Infection","ValueMeaning":{"publicId":"4395783","version":"1","preferredName":"Urinary Tract Infection","longName":"4395783","preferredDefinition":"A bacterial infectious process affecting any part of the urinary tract, most commonly the bladder and the urethra. Symptoms include urinary urgency and frequency, burning sensation during urination, lower abdominal discomfort, and cloudy urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urinary Tract Infection","conceptCode":"C50791","definition":"A bacterial infectious process affecting any part of the urinary tract, most commonly the bladder and the urethra. Symptoms include urinary urgency and frequency, burning sensation during urination, lower abdominal discomfort, and cloudy urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DAF0-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFCF8C-4C29-6866-E053-F662850A6631","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Uterine Prolapse","valueDescription":"Uterine Prolapse","ValueMeaning":{"publicId":"6834712","version":"1","preferredName":"Uterine Prolapse","longName":"6834712","preferredDefinition":"The sliding of the uterus into the vaginal canal. It results from the weakening of the pelvic floor muscles and ligaments and is usually seen in postmenopausal women with several vaginal deliveries. Clinical manifestations include sensation of heaviness in the pelvis, urinary difficulties, and tissue protrusion from the vagina.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Prolapse","conceptCode":"C35108","definition":"The sliding of the uterus into the vaginal canal. It results from the weakening of the pelvic floor muscles and ligaments and is usually seen in postmenopausal women with several vaginal deliveries. Clinical manifestations include sensation of heaviness in the pelvis, urinary difficulties, and tissue protrusion from the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFD63E-71FA-718C-E053-F662850A5416","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFD63E-7215-718C-E053-F662850A5416","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Acute Glomerulonephritis","valueDescription":"Acute Glomerulonephritis","ValueMeaning":{"publicId":"6840919","version":"1","preferredName":"Acute Glomerulonephritis","longName":"6840919","preferredDefinition":"An acute inflammation of the glomeruli, generally secondary to infection or injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Glomerulonephritis","conceptCode":"C35213","definition":"An acute inflammation of the glomeruli, generally secondary to infection or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8D69C-5A9B-6E96-E053-F662850A325C","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5AB4-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Acute Hepatitis B Infection","valueDescription":"Acute Hepatitis B Infection","ValueMeaning":{"publicId":"6840921","version":"1","preferredName":"Acute Hepatitis B Infection","longName":"6840921","preferredDefinition":"A new infection by the hepatitis B virus, which can be transmitted by direct contact of infected blood with mucous membranes or open areas of the skin. Signs and symptoms may include loss of appetite, joint and muscle pain, low-grade fever and stomach pain. Two to six percent of adults progress to a chronic infection, while 90% of infants become chronically ill. A vaccine is available for those at risk.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Hepatitis B Infection","conceptCode":"C157781","definition":"A new infection by the hepatitis B virus, which can be transmitted by direct contact of infected blood with mucous membranes or open areas of the skin. Signs and symptoms may include loss of appetite, joint and muscle pain, low-grade fever and stomach pain. Two to six percent of adults progress to a chronic infection, while 90% of infants become chronically ill. A vaccine is available for those at risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8D69C-5AC1-6E96-E053-F662850A325C","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5ADA-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Acute Hepatitis C Infection","valueDescription":"Acute Hepatitis C Infection","ValueMeaning":{"publicId":"6840923","version":"1","preferredName":"Acute Hepatitis C Infection","longName":"6840923","preferredDefinition":"A new infection by the hepatitis C virus, which can be detected in blood. Signs and symptoms may include right upper quadrant abdominal pain, jaundice, dark urine, white stools and nausea. Approximately 15%-25% individuals clear the virus from their bodies without treatment. 75%-85% individuals develop chronic hepatitis C. There are possible treatments depending on individual characteristics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Hepatitis C Infection","conceptCode":"C157782","definition":"A new infection by the hepatitis C virus, which can be detected in blood. Signs and symptoms may include right upper quadrant abdominal pain, jaundice, dark urine, white stools and nausea. Approximately 15%-25% individuals clear the virus from their bodies without treatment. 75%-85% individuals develop chronic hepatitis C. There are possible treatments depending on individual characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8D69C-5AE7-6E96-E053-F662850A325C","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5B00-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Acute Hepatitis E Infection","valueDescription":"Acute Hepatitis E Infection","ValueMeaning":{"publicId":"6840925","version":"1","preferredName":"Acute Hepatitis E Infection","longName":"6840925","preferredDefinition":"A new infection by the hepatitis E virus, which is usually spread by the fecal-oral route. Signs and symptoms may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, jaundice, dark urine, clay-colored stools and joint pain. There is no specific anti-viral treatment, the infection resolves on its own.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Hepatitis E Infection","conceptCode":"C157783","definition":"A new infection by the hepatitis E virus, which is usually spread by the fecal-oral route. Signs and symptoms may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, jaundice, dark urine, clay-colored stools and joint pain. There is no specific anti-viral treatment, the infection resolves on its own.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8D69C-5B0D-6E96-E053-F662850A325C","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5B26-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"African Trypanosomiasis","valueDescription":"African Trypanosomiasis","ValueMeaning":{"publicId":"3210849","version":"1","preferredName":"African Trypanosomiasis","longName":"3210849","preferredDefinition":"A parasitic disorder caused by protozoa of the Trypanosoma brucei species. It is transmitted by flies and is endemic in various regions of Sub-Saharan Africa. Signs and symptoms include fever, joint pain, headache, and significant swelling of the lymph nodes. If left untreated, the parasitic infection causes anemia, heart, kidney, and endocrine failure, and neurologic damage. Subsequently patients develop confusion, disruption of the sleep cycle, and mental deterioration. The infection may lead to coma and death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"African Trypanosomiasis","conceptCode":"C84541","definition":"A parasitic disorder caused by protozoa of the Trypanosoma brucei species. It is transmitted by flies and is endemic in various regions of Sub-Saharan Africa. Signs and symptoms include fever, joint pain, headache, and significant swelling of the lymph nodes. If left untreated, the parasitic infection causes anemia, heart, kidney, and endocrine failure, and neurologic damage. Subsequently patients develop confusion, disruption of the sleep cycle, and mental deterioration. The infection may lead to coma and death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-AA38-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8D69C-5B30-6E96-E053-F662850A325C","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Chronic Obstructive Pulmonary Disease","valueDescription":"Chronic Obstructive Pulmonary Disease","ValueMeaning":{"publicId":"4395784","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease","longName":"4395784","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DB13-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D0C-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Alcoholic Cirrhosis","valueDescription":"Alcoholic Cirrhosis","ValueMeaning":{"publicId":"3249575","version":"1","preferredName":"Alcoholic Cirrhosis","longName":"3249575","preferredDefinition":"Liver cirrhosis in alcoholics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcoholic Cirrhosis","conceptCode":"C34782","definition":"A disorder of the liver characterized by the presence of fibrotic scar tissue instead of healthy liver tissue. This condition is attributed to excessive consumption of alcoholic beverages.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D99025-BD91-DBB4-E040-BB89AD434418","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-0872-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Alcohol-Related Hepatocellular Carcinoma","valueDescription":"Alcohol-Related Hepatocellular Carcinoma","ValueMeaning":{"publicId":"6840931","version":"1","preferredName":"Alcohol-Related Hepatocellular Carcinoma","longName":"6840931","preferredDefinition":"A hepatocellular carcinoma that develops following alcohol-induced injury of the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol-Related Hepatocellular Carcinoma","conceptCode":"C27924","definition":"A hepatocellular carcinoma that develops following alcohol-induced injury of the liver parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-0880-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-0899-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Alzheimer's Disease","valueDescription":"Alzheimer's Disease","ValueMeaning":{"publicId":"3165575","version":"1","preferredName":"Alzheimer's Disease","longName":"3165575","preferredDefinition":"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease","conceptCode":"C2866","definition":"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C22C-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-08A3-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Amoebiasis","valueDescription":"Amoebiasis","ValueMeaning":{"publicId":"6840933","version":"1","preferredName":"Amoebiasis","longName":"6840933","preferredDefinition":"A parasitic infection of the colon by Entamoeba histolytica. Signs and symptoms include cramping, diarrhea, bloody stools and fever. It can be treated with antibiotics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Amoebiasis","conceptCode":"C157785","definition":"A parasitic infection of the colon by Entamoeba histolytica. Signs and symptoms include cramping, diarrhea, bloody stools and fever. It can be treated with antibiotics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-08B0-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-08C9-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Amphetamine Use Disorder","valueDescription":"Amphetamine Use Disorder","ValueMeaning":{"publicId":"6840935","version":"1","preferredName":"Amphetamine Use Disorder","longName":"6840935","preferredDefinition":"The use of amphetamines that results in the development of a dependency that adversely affects an individual's life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Amphetamine Use Disorder","conceptCode":"C157786","definition":"The use of amphetamines that results in the development of a dependency that adversely affects an individual's life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-08D6-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-08EF-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Aortic Aneurysm","valueDescription":"Aortic Aneurysm","ValueMeaning":{"publicId":"6840936","version":"1","preferredName":"Aortic Aneurysm","longName":"6840936","preferredDefinition":"A sac formation resulting from the localized dilatation of the wall of the aorta.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aortic Aneurysm","conceptCode":"C26697","definition":"A sac formation resulting from the localized dilatation of the wall of the aorta.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-08FB-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-0914-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Appendicitis","valueDescription":"Acute Appendicitis","ValueMeaning":{"publicId":"2944024","version":"1","preferredName":"Acute Appendicitis","longName":"2944024","preferredDefinition":"Acute inflammation of the vermiform appendix.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Appendicitis","conceptCode":"C35145","definition":"Acute inflammation of the vermiform appendix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-12EF-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-091E-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Ascariasis","valueDescription":"Ascariasis","ValueMeaning":{"publicId":"6840938","version":"1","preferredName":"Ascariasis","longName":"6840938","preferredDefinition":"An infection that is caused by the roundworm Ascaris lumbricoides, many cases of which remain asymptomatic. During the transient larval migratory phase, shortness of breath, fever, and eosinophilia can occur. Depending on the intestinal worm burden, a spectrum of gastrointestinal tract symptoms can occur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ascariasis","conceptCode":"C128392","definition":"An infection that is caused by the roundworm Ascaris lumbricoides, many cases of which remain asymptomatic. During the transient larval migratory phase, shortness of breath, fever, and eosinophilia can occur. Depending on the intestinal worm burden, a spectrum of gastrointestinal tract symptoms can occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-092C-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-0945-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Assault","valueDescription":"Assault","ValueMeaning":{"publicId":"6840940","version":"1","preferredName":"Assault","longName":"6840940","preferredDefinition":"A physical attack.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assault","conceptCode":"C157707","definition":"A physical attack.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-0952-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-096B-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Assault By Firearm","valueDescription":"Assault By Firearm","ValueMeaning":{"publicId":"6840942","version":"1","preferredName":"Assault By Firearm","longName":"6840942","preferredDefinition":"A physical attack with a gun.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assault By Firearm","conceptCode":"C157790","definition":"A physical attack with a gun.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-0978-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-0991-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Assault By Sharp Object","valueDescription":"Assault By Sharp Object","ValueMeaning":{"publicId":"6840944","version":"1","preferredName":"Assault By Sharp Object","longName":"6840944","preferredDefinition":"A physical attack with a pointed object.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assault By Sharp Object","conceptCode":"C157791","definition":"A physical attack with a pointed object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-099E-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-09B7-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Asthma","valueDescription":"Asthma","ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-09C1-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Atrial Fibrillation","valueDescription":"Atrial Fibrillation","ValueMeaning":{"publicId":"2760267","version":"1","preferredName":"Atrial Fibrillation","longName":"2760267","preferredDefinition":"A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atrial Fibrillation","conceptCode":"C50466","definition":"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3C42-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-09CC-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Atrial Flutter","valueDescription":"Atrial Flutter","ValueMeaning":{"publicId":"2944033","version":"1","preferredName":"Atrial Flutter","longName":"2944033","preferredDefinition":"An electrocardiographic finding of an organized rhythmic contraction of the atria which is generally at a rate of 200-300 beats per minute.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atrial Flutter","conceptCode":"C51224","definition":"A disorder characterized by an electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth-like pattern between the QRS complexes. (CDISC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-13D6-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-09D6-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Bacterial Skin Disorder","valueDescription":"Bacterial Skin Disorder","ValueMeaning":{"publicId":"6840946","version":"1","preferredName":"Bacterial Skin Disorder","longName":"6840946","preferredDefinition":"A cutaneous disorder attributed to a bacterial infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacterial Skin Disorder","conceptCode":"C157794","definition":"A cutaneous disorder attributed to a bacterial infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8E9A3-09E4-6132-E053-F662850A2F4E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE8E9A3-09FD-6132-E053-F662850A2F4E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Bronchogenic Carcinoma","valueDescription":"Bronchogenic Carcinoma","ValueMeaning":{"publicId":"3210692","version":"1","preferredName":"Bronchogenic Carcinoma","longName":"3210692","preferredDefinition":"A lung carcinoma arising from the bronchial epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchogenic Carcinoma","conceptCode":"C35875","definition":"A lung carcinoma arising from the bronchial epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-8EF8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9159F-8F81-6F18-E053-F662850AB8C3","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Breast Carcinoma","valueDescription":"Breast Carcinoma","ValueMeaning":{"publicId":"5581329","version":"1","preferredName":"Breast Carcinoma","longName":"5581329","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9159F-8F8B-6F18-E053-F662850AB8C3","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Bowel Obstruction","valueDescription":"Bowel obstruction","ValueMeaning":{"publicId":"3244611","version":"1","preferredName":"Bowel obstruction","longName":"3244611","preferredDefinition":"Any impairment, arrest, or reversal of the normal flow of intestinal contents toward the anus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bowel Obstruction","conceptCode":"C9175","definition":"Blockage of the normal flow of the intestinal contents within the bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5C1ACC0-23E5-9BBA-E040-BB89AD4314F9","latestVersionIndicator":"Yes","beginDate":"2011-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-06-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9159F-8FA1-6F18-E053-F662850AB8C3","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Blood Disease","valueDescription":"Hematologic and Lymphocytic Disorder","ValueMeaning":{"publicId":"6840949","version":"1","preferredName":"Hematologic and Lymphocytic Disorder","longName":"6840949","preferredDefinition":"A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic and Lymphoid Cell Disorder","conceptCode":"C26323","definition":"A non-neoplastic or neoplastic disorder that arises from the hematopoietic and lymphoid cells. Representative examples include disorders that affect the synthesis of hemoglobin, coagulation disorders, leukemias, and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9159F-8FAC-6F18-E053-F662850AB8C3","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9159F-8FC5-6F18-E053-F662850AB8C3","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Behavior-Related Disorder","valueDescription":"Behavior-Related Disorder","ValueMeaning":{"publicId":"6840950","version":"1","preferredName":"Behavior-Related Disorder","longName":"6840950","preferredDefinition":"A specific behavioral problem that occurs in persistent patterns and characteristic clusters and that causes clinically significant impairment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Behavioral Disorder","conceptCode":"C35470","definition":"A specific behavioral problem that occurs in persistent patterns and characteristic clusters and that causes clinically significant impairment.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9159F-8FD1-6F18-E053-F662850AB8C3","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9159F-8FEA-6F18-E053-F662850AB8C3","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Bladder Carcinoma","valueDescription":"Bladder Carcinoma","ValueMeaning":{"publicId":"5581326","version":"1","preferredName":"Bladder Carcinoma","longName":"5581326","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B667-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9159F-9000-6F18-E053-F662850AB8C3","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Chronic Kidney Disease due to Diabetes Mellitus","valueDescription":"Chronic Kidney Disease due to Diabetes Mellitus","ValueMeaning":{"publicId":"6840960","version":"1","preferredName":"Chronic Kidney Disease due to Diabetes Mellitus","longName":"6840960","preferredDefinition":"Longstanding kidney disease as a complication of diabetes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease due to Diabetes Mellitus","conceptCode":"C157813","definition":"Longstanding kidney disease as a complication of diabetes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7CE9-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D02-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Chronic Respiratory Disease","valueDescription":"Chronic Respiratory Disease","ValueMeaning":{"publicId":"6840962","version":"1","preferredName":"Chronic Respiratory Disease","longName":"6840962","preferredDefinition":"Longstanding disease of the lungs and/or the respiratory tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Neoplastic Chronic Respiratory System Disorder","conceptCode":"C157816","definition":"A non-neoplastic longstanding disorder of the respiratory system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7D19-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D32-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D3E-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cirrhosis of the Liver Secondary to Hepatitis B","valueDescription":"Cirrhosis of the Liver Secondary to Hepatitis B","ValueMeaning":{"publicId":"6840964","version":"1","preferredName":"Cirrhosis of the Liver Secondary to Hepatitis B","longName":"6840964","preferredDefinition":"Cirrhosis of the liver that develops as a sequelae of a hepatitis b infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis of the Liver Secondary to Hepatitis B","conceptCode":"C157817","definition":"Cirrhosis of the liver that develops as a sequelae of a hepatitis b infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7D4B-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D64-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cirrhosis of the Liver Secondary to Hepatitis C","valueDescription":"Cirrhosis of the Liver Secondary to Hepatitis C","ValueMeaning":{"publicId":"6840966","version":"1","preferredName":"Cirrhosis of the Liver Secondary to Hepatitis C","longName":"6840966","preferredDefinition":"Cirrhosis of the liver that develops as a sequelae of a hepatitis c infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis of the Liver Secondary to Hepatitis C","conceptCode":"C157818","definition":"Cirrhosis of the liver that develops as a sequelae of a hepatitis c infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7D71-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D8A-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cleft Lip","valueDescription":"Cleft Lip","ValueMeaning":{"publicId":"4920016","version":"1","preferredName":"Cleft Lip","longName":"4920016","preferredDefinition":"A congenital abnormality consisting of one or more clefts (splits) in the upper lip, which may be accompanied by a cleft palate; it is the result of the failure of the embryonic parts of the lip to fuse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cleft Lip","conceptCode":"C87175","definition":"A congenital abnormality consisting of one or more clefts (splits) in the upper lip, which may be accompanied by a cleft palate; it is the result of the failure of the embryonic parts of the lip to fuse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8FCB10-6F09-B06E-E050-BB89AD430721","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D94-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cleft Palate","valueDescription":"Cleft Palate","ValueMeaning":{"publicId":"4920014","version":"1","preferredName":"Cleft Palate","longName":"4920014","preferredDefinition":"A congenital abnormality consisting of a fissure in the midline of the hard and/or soft palate; it is the result of the failure of the two sides of the palate to fuse during embryonic development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cleft Palate","conceptCode":"C87069","definition":"A congenital abnormality consisting of a fissure in the midline of the hard and/or soft palate; it is the result of the failure of the two sides of the palate to fuse during embryonic development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8FCB10-6EE3-B06E-E050-BB89AD430721","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7D9F-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cocaine Use Disorder","valueDescription":"Cocaine Use Disorder","ValueMeaning":{"publicId":"6840968","version":"1","preferredName":"Cocaine Use Disorder","longName":"6840968","preferredDefinition":"The use of cocaine that results in the development of a dependency that adversely affects an individual's life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cocaine Use Disorder","conceptCode":"C157819","definition":"The use of cocaine that results in the development of a dependency that adversely affects an individual's life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7DAD-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7DC6-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Colon Carcinoma","valueDescription":"Colon Carcinoma","ValueMeaning":{"publicId":"5581331","version":"1","preferredName":"Colon Carcinoma","longName":"5581331","preferredDefinition":"A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Carcinoma","conceptCode":"C4910","definition":"A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B716-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7DD0-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Communicable Disorder","valueDescription":"Communicable Disorder","ValueMeaning":{"publicId":"6840970","version":"1","preferredName":"Communicable Disorder","longName":"6840970","preferredDefinition":"A disease that can be transmitted from one individual to another.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Communicable Disorder","conceptCode":"C157825","definition":"A disease that can be transmitted from one individual to another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7DDD-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7DF6-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Congenital Abnormality","valueDescription":"Congenital Abnormality","ValueMeaning":{"publicId":"2993000","version":"1","preferredName":"Congenital Abnormality","longName":"2993000","preferredDefinition":"Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Abnormality","conceptCode":"C2849","definition":"Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E1461A5-7AB2-590A-E040-BB89AD436E02","latestVersionIndicator":"Yes","beginDate":"2010-01-26","endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E00-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Congenital Heart Disease","valueDescription":"Congenital Heart Disease","ValueMeaning":{"publicId":"3248584","version":"1","preferredName":"Congenital Heart Disease","longName":"3248584","preferredDefinition":"A heart abnormality that is present at birth. Representative examples include atrial septal defect, ventricular septal defect, tetralogy of Fallot, and patent foramen ovale","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Heart Disease","conceptCode":"C95834","definition":"A heart disease that is present at birth. Representative examples include atrial septal defect, ventricular septal defect, tetralogy of Fallot, and patent foramen ovale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-C04B-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E15-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cryptosporidiosis","valueDescription":"Cryptosporidiosis","ValueMeaning":{"publicId":"6840972","version":"1","preferredName":"Cryptosporidiosis","longName":"6840972","preferredDefinition":"An infection that is caused by Cryptosporidium parvum or hominis, which is acquired by inhalation or ingestion of infectious spores, and which typically manifests as acute enteritis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryptosporidiosis","conceptCode":"C128408","definition":"An infection that is caused by Cryptosporidium parvum or hominis, which is acquired by inhalation or ingestion of infectious spores, and which typically manifests as acute enteritis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7E23-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E3C-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Alcohol Abuse","valueDescription":"Alcohol Abuse","ValueMeaning":{"publicId":"6840952","version":"1","preferredName":"Alcohol Abuse","longName":"6840952","preferredDefinition":"The use of alcoholic beverages to excess, either on individual occasions (\"binge drinking\") or as a regular practice.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol Abuse","conceptCode":"C20701","definition":"The use of alcoholic beverages to excess, either on individual occasions (\"binge drinking\") or as a regular practice.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE93A57-26B1-418B-E053-F662850ABA64","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-26CB-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Campylobacter Enteritis","valueDescription":"Campylobacter Enteritis","ValueMeaning":{"publicId":"6840954","version":"1","preferredName":"Campylobacter Enteritis","longName":"6840954","preferredDefinition":"A gastrointestinal infection attributed to the bacteria campylobacter. It is usually contracted by consuming raw or undercooked poultry or consuming a food that has been in contact with raw poultry. It is characterized by abdominal pain, fever, and  diarrhea and usually resolves in two to five days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Campylobacter Enteritis","conceptCode":"C157804","definition":"A gastrointestinal infection attributed to the bacteria campylobacter. It is usually contracted by consuming raw or undercooked poultry or consuming a food that has been in contact with raw poultry. It is characterized by abdominal pain, fever, and  diarrhea and usually resolves in two to five days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE93A57-26D9-418B-E053-F662850ABA64","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-26F2-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cardiomyopathy","valueDescription":"Cardiomyopathy","ValueMeaning":{"publicId":"2585212","version":"1","preferredName":"Cardiomyopathy","longName":"2585212","preferredDefinition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiomyopathy","conceptCode":"C34830","definition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9B74-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-26FC-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cellulitis","valueDescription":"Cellulitis","ValueMeaning":{"publicId":"2746221","version":"1","preferredName":"Cellulitis","longName":"2746221","preferredDefinition":"An acute, spreading infection of the deep tissues of the skin and muscle that causes the skin to become warm and tender and may also cause fever, chills, swollen lymph nodes, and blisters.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellulitis","conceptCode":"C26715","definition":"Inflammation of the dermis and subcutaneous tissues caused by a bacterial infection. Symptoms include erythema, edema, and pain to the affected area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FE0C-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-2707-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cerebrovascular Disorder","valueDescription":"Cerebrovascular Disorder","ValueMeaning":{"publicId":"2970710","version":"1","preferredName":"Cerebrovascular Disorder","longName":"2970710","preferredDefinition":"A broad category of disorders characterized by impairment of blood flow in the arteries and veins which supply the brain. These include CEREBRAL INFARCTION; BRAIN ISCHEMIA; HYPOXIA, BRAIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and VASCULITIS, CENTRAL NERVOUS SYSTEM. In common usage, the term cerebrovascular disorders is not limited to conditions that affect the cerebrum, but refers to vascular disorders of the entire brain including the DIENCEPHALON; BRAIN STEM; and CEREBELLUM.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebrovascular Disorder","conceptCode":"C2938","definition":"A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B03BA39-F9B5-A853-E040-BB89AD433913","latestVersionIndicator":"Yes","beginDate":"2009-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-2714-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cervical Carcinoma","valueDescription":"Cervical Carcinoma","ValueMeaning":{"publicId":"5581330","version":"1","preferredName":"Cervical Carcinoma","longName":"5581330","preferredDefinition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Carcinoma","conceptCode":"C9039","definition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are squamous cell carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6F3-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-272A-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Chagas Disease","valueDescription":"Chagas Disease","ValueMeaning":{"publicId":"3210951","version":"1","preferredName":"Chagas Disease","longName":"3210951","preferredDefinition":"A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chagas Disease","conceptCode":"C84629","definition":"A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B8E2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-2735-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Chicken Pox","valueDescription":"Chicken Pox","ValueMeaning":{"publicId":"6840956","version":"1","preferredName":"Chicken Pox","longName":"6840956","preferredDefinition":"A contagious childhood disorder caused by the varicella zoster virus. It is transmitted via respiratory secretions and contact with chickenpox blister contents. It presents with a vesicular skin rash, usually associated with fever, headache, and myalgias. The pruritic fluid-filled vesicles occur 10-21 days after exposure and last for 3-4 days. An additional 3-4 days of malaise follows before the affected individual feels better. An individual is contagious 1-2 days prior to the appearance of the blisters until all blisters are crusted over. Generally, healthy individuals recover without complications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chicken Pox","conceptCode":"C97132","definition":"A contagious childhood disorder caused by the varicella zoster virus. It is transmitted via respiratory secretions and contact with chickenpox blister contents. It presents with a vesicular skin rash, usually associated with fever, headache, and myalgias. The pruritic fluid-filled vesicles occur 10-21 days after exposure and last for 3-4 days. An additional 3-4 days of malaise follows before the affected individual feels better. An individual is contagious 1-2 days prior to the appearance of the blisters until all blisters are crusted over. Generally, healthy individuals recover without complications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE93A57-2743-418B-E053-F662850ABA64","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-275C-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cholera","valueDescription":"Cholera","ValueMeaning":{"publicId":"6840958","version":"1","preferredName":"Cholera","longName":"6840958","preferredDefinition":"An acute diarrheal illness caused by consuming water or food contaminated by the bacterium Vibrio cholerae. Adequate rehydration is key to surviving this illness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholera","conceptCode":"C157812","definition":"An acute diarrheal illness caused by consuming water or food contaminated by the bacterium Vibrio cholerae. Adequate rehydration is key to surviving this illness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE93A57-2769-418B-E053-F662850ABA64","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-2782-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Chronic Kidney Disease","valueDescription":"Chronic Kidney Disease","ValueMeaning":{"publicId":"2944301","version":"1","preferredName":"Chronic Kidney Disease","longName":"2944301","preferredDefinition":"Gradual and usually permanent loss of kidney function resulting in renal failure. Causes include diabetes, hypertension, and glomerulonephritis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease","conceptCode":"C80078","definition":"Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4EFE-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE93A57-278C-418B-E053-F662850ABA64","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cutaneous Melanoma","valueDescription":"Cutaneous Melanoma","ValueMeaning":{"publicId":"2860482","version":"1","preferredName":"Cutaneous Melanoma","longName":"2860482","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67719CEB-4934-A191-E040-BB89AD430A4C","latestVersionIndicator":"Yes","beginDate":"2009-04-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E50-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cysticercosis","valueDescription":"Cysticercosis","ValueMeaning":{"publicId":"3211000","version":"1","preferredName":"Cysticercosis","longName":"3211000","preferredDefinition":"A parasitic infection caused by the larval form of Taenia solium. It is a disseminated infection affecting the central nervous system, subcutaneous tissues, lungs, heart and liver. The most serious complications result from infection of the brain parenchyma. Patients may develop seizures, hydrocephalus, encephalopathy and meningoencephalitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cysticercosis","conceptCode":"C34520","definition":"A parasitic infection caused by the larval form of Taenia solium. It is a disseminated infection affecting the central nervous system, subcutaneous tissues, lungs, heart and liver. The most serious complications result from infection of the brain parenchyma. Patients may develop seizures, hydrocephalus, encephalopathy and meningoencephalitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BFC4-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E5B-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cytogenetic Abnormality","valueDescription":"Cytogenetic Abnormality","ValueMeaning":{"publicId":"3210961","version":"1","preferredName":"Cytogenetic Abnormality","longName":"3210961","preferredDefinition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Abnormality","conceptCode":"C2950","definition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BA5E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E67-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Dementia","valueDescription":"Dementia","ValueMeaning":{"publicId":"3165569","version":"1","preferredName":"Dementia","longName":"3165569","preferredDefinition":"An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dementia","conceptCode":"C4786","definition":"Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C196-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E72-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Dengue Fever","valueDescription":"Dengue Fever","ValueMeaning":{"publicId":"3211010","version":"1","preferredName":"Dengue Fever","longName":"3211010","preferredDefinition":"An acute infection caused by Dengue virus. Signs and symptoms include sudden onset of fever, headache, rash, arthralgia, and myalgia. It is transmitted through mosquitoes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dengue Fever","conceptCode":"C34528","definition":"An acute infection caused by Dengue virus. Signs and symptoms include sudden onset of fever, headache, rash, arthralgia, and myalgia. It is transmitted through mosquitoes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C118-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E7D-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E8A-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"4395762","version":"1","preferredName":"Diarrhea","longName":"4395762","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D82F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7E97-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Digestive System Disorder","valueDescription":"Gastrointestinal Disorder","ValueMeaning":{"publicId":"2578545","version":"1","preferredName":"Gastrointestinal Disorder","longName":"2578545","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the gastrointestinal tract, anus, liver, biliary system, and pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Digestive System Disorder","conceptCode":"C2990","definition":"A non-neoplastic or neoplastic disorder that affects the gastrointestinal tract, anus, liver, biliary system, and pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFDE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7EAD-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Diphtheria","valueDescription":"Diphtheria","ValueMeaning":{"publicId":"3235518","version":"1","preferredName":"Diphtheria","longName":"3235518","preferredDefinition":"A Gram-positive bacterial infection caused by Corynebacterium diphtheria.  It usually involves the oral cavity, pharynx, and nasal cavity.  Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection.  The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diphtheria","conceptCode":"C34541","definition":"A Gram-positive bacterial infection caused by Corynebacterium diphtheriae. It usually involves the oral cavity, pharynx, and nasal cavity. Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection. The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-1A17-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7EC2-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Down Syndrome","valueDescription":"Down Syndrome","ValueMeaning":{"publicId":"2730288","version":"1","preferredName":"Down Syndrome","longName":"2730288","preferredDefinition":"A disorder caused by the presence of an extra chromosome 21 and characterized by mental retardation and distinguishing physical features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Down Syndrome","conceptCode":"C2993","definition":"A chromosomal dysgenesis syndrome resulting from a triplication or translocation of chromosome 21. Down syndrome occurs in approximately 1:700 live births. Abnormalities are variable from individual to individual and may include mental retardation, retarded growth, flat hypoplastic face with short nose, prominent epicanthic skin folds, small low-set ears with prominent antihelix, fissured and thickened tongue, laxness of joint ligaments, pelvic dysplasia, broad hands and feet, stubby fingers, transverse palmar crease, lenticular opacities and heart disease. Patients with Down syndrome have an estimated 10 to 30-fold increased risk for leukemia; most have symptoms of Alzheimer's disease by age 40. Also known as trisomy 21 syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"468669DD-300B-4A98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7ECE-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Drug Abuse","valueDescription":"Drug Abuse","ValueMeaning":{"publicId":"6840973","version":"1","preferredName":"Drug Abuse","longName":"6840973","preferredDefinition":"The use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Abuse","conceptCode":"C16522","definition":"The use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE96A5D-7ED9-5CF8-E053-F662850A632F","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE96A5D-7EF4-5CF8-E053-F662850A632F","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Duodenitis","valueDescription":"Duodenitis","ValueMeaning":{"publicId":"6841418","version":"1","preferredName":"Duodenitis","longName":"6841418","preferredDefinition":"Acute or chronic inflammation of the duodenum. Causes include bacterial and viral infections and gastroesophageal reflux disease. Symptoms include vomiting and abdominal pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Duodenitis","conceptCode":"C94409","definition":"Acute or chronic inflammation of the duodenum. Causes include bacterial and viral infections and gastroesophageal reflux disease. Symptoms include vomiting and abdominal pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EED093D-7566-1052-E053-F662850A9CEA","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-757F-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Eating Disorder","valueDescription":"Eating Disorder","ValueMeaning":{"publicId":"6841419","version":"1","preferredName":"Eating Disorder","longName":"6841419","preferredDefinition":"A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eating Disorder","conceptCode":"C89332","definition":"A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EED093D-7589-1052-E053-F662850A9CEA","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75A2-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Echinococcosis","valueDescription":"Echinococcosis","ValueMeaning":{"publicId":"3211033","version":"1","preferredName":"Echinococcosis","longName":"3211033","preferredDefinition":"A parasitic infection caused by tapeworm larvae of Echinococcus. It affects livestock and humans. It is characterized by the formation of hydatid cysts mainly in the liver, lungs, spleen, and kidneys. Rupture of the cysts may lead to shock.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Echinococcosis","conceptCode":"C84682","definition":"A parasitic infection caused by tapeworm larvae of Echinococcus. It affects livestock and humans. It is characterized by the formation of hydatid cysts mainly in the liver, lungs, spleen, and kidneys. Rupture of the cysts may lead to shock.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C466-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75AC-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Encephalitis","valueDescription":"Encephalitis","ValueMeaning":{"publicId":"3211040","version":"1","preferredName":"Encephalitis","longName":"3211040","preferredDefinition":"An acute inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Encephalitis","conceptCode":"C26760","definition":"An inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C554-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75B7-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Endocarditis","valueDescription":"Endocarditis","ValueMeaning":{"publicId":"3210744","version":"1","preferredName":"Endocarditis","longName":"3210744","preferredDefinition":"Inflammation of the endocardium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocarditis","conceptCode":"C34582","definition":"Inflammation of the endocardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9860-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75C2-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Endocrine System Disorder","valueDescription":"Endocrine Disorder","ValueMeaning":{"publicId":"2578544","version":"1","preferredName":"Endocrine Disorder","longName":"2578544","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocrine System Disorder","conceptCode":"C3009","definition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFDD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75D7-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Endometriosis","valueDescription":"Endometriosis","ValueMeaning":{"publicId":"3210813","version":"1","preferredName":"Endometriosis","longName":"3210813","preferredDefinition":"The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometriosis","conceptCode":"C3014","definition":"The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A444-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75E2-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Esophageal Carcinoma","valueDescription":"Esophageal Carcinoma","ValueMeaning":{"publicId":"5581332","version":"1","preferredName":"Esophageal Carcinoma","longName":"5581332","preferredDefinition":"A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Carcinoma","conceptCode":"C3513","definition":"A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B739-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-75F6-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Fall","valueDescription":"Fall","ValueMeaning":{"publicId":"2944776","version":"1","preferredName":"Fall","longName":"2944776","preferredDefinition":"A sudden movement downward, usually resulting in injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fall","conceptCode":"C50558","definition":"A sudden movement downward, usually resulting in injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7443E93B-ADB6-B364-E040-BB89AD434621","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"DWARZEL","dateModified":"2016-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-7601-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Femoral Hernia","valueDescription":"Femoral Hernia","ValueMeaning":{"publicId":"6841421","version":"1","preferredName":"Femoral Hernia","longName":"6841421","preferredDefinition":"The protrusion of contents of the abdominal cavity, into the weak area at the posterior wall of the femoral canal, just inferior to the inguinal ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Femoral Hernia","conceptCode":"C34689","definition":"The protrusion of contents of the abdominal cavity, into the weak area at the posterior wall of the femoral canal, just inferior to the inguinal ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EED093D-760F-1052-E053-F662850A9CEA","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-7628-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Gallbladder Carcinoma","valueDescription":"Gallbladder Carcinoma","ValueMeaning":{"publicId":"5581349","version":"1","preferredName":"Gallbladder Carcinoma","longName":"5581349","preferredDefinition":"A malignant tumor arising from the epithelium of the gallbladder. It is usually associated with the presence of gallstones. Clinical symptoms are not specific and usually present late in the course. Morphologically, most gallbladder carcinomas are adenocarcinomas; squamous cell carcinomas, adenosquamous carcinomas, signet ring carcinomas, and undifferentiated carcinomas can also occur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Carcinoma","conceptCode":"C3844","definition":"A malignant tumor arising from the epithelium of the gallbladder. It is usually associated with the presence of gallstones. Clinical symptoms are not specific and usually present late in the course. Morphologically, most gallbladder carcinomas are adenocarcinomas; squamous cell carcinomas, adenosquamous carcinomas, signet ring carcinomas, and undifferentiated carcinomas can also occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B997-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-7632-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Gallbladder Disorder","valueDescription":"Gallbladder Disorder","ValueMeaning":{"publicId":"6660933","version":"1","preferredName":"Gallbladder Disorder","longName":"6660933","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the gallbladder. Representative examples of non-neoplastic disorders include acute and chronic cholecystitis, often associated with the presence of gallstones. Representative examples of neoplastic disorders include adenoma, carcinoma, lymphoma, and sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Disorder","conceptCode":"C34631","definition":"A non-neoplastic or neoplastic disorder that affects the gallbladder. Representative examples of non-neoplastic disorders include acute and chronic cholecystitis, often associated with the presence of gallstones. Representative examples of neoplastic disorders include adenoma, carcinoma, lymphoma, and sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-57FE-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-763C-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Gastric Carcinoma","valueDescription":"Gastric Carcinoma","ValueMeaning":{"publicId":"5581343","version":"1","preferredName":"Gastric Carcinoma","longName":"5581343","preferredDefinition":"A malignant epithelial tumor of the stomach mucosa. The vast majority of gastric carcinomas are adenocarcinomas, arising from the gastric glandular epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Carcinoma","conceptCode":"C4911","definition":"A malignant epithelial tumor of the stomach mucosa. The vast majority of gastric carcinomas are adenocarcinomas, arising from the gastric glandular epithelium.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8C5-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-7647-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Gastritis","valueDescription":"Gastritis","ValueMeaning":{"publicId":"2746385","version":"1","preferredName":"Gastritis","longName":"2746385","preferredDefinition":"Inflammation of the lining of the stomach.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastritis","conceptCode":"C26780","definition":"Inflammation of the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-72BF-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-7651-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Glucose-6-Phosphate Dehydrogenase Deficiency","valueDescription":"Glucose-6-Phosphate Dehydrogenase Deficiency","ValueMeaning":{"publicId":"5944606","version":"1","preferredName":"Glucose-6-Phosphate Dehydrogenase Deficiency","longName":"5944606","preferredDefinition":"An X-linked recessive inherited disorder caused by mutations in the G6PD gene. It is characterized by the absence or presence of very low levels of glucose-6-phosphate dehydrogenase. Patients develop hemolytic anemia usually in response to infection or exposure to drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucose-6-Phosphate Dehydrogenase Deficiency","conceptCode":"C98933","definition":"An X-linked recessive inherited disorder caused by mutations in the G6PD gene. It is characterized by the absence or presence of very low levels of glucose-6-phosphate dehydrogenase. Patients develop hemolytic anemia usually in response to infection or exposure to drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57E9DF54-BE0A-7A61-E053-F662850A15E0","latestVersionIndicator":"Yes","beginDate":"2017-08-29","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-08-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-7665-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Gonococcal Infection","valueDescription":"Gonococcal Infection","ValueMeaning":{"publicId":"6841423","version":"1","preferredName":"Gonococcal Infection","longName":"6841423","preferredDefinition":"An infection that is caused by Gonococcus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gonococcal Infection","conceptCode":"C35730","definition":"An infection that is caused by Gonococcus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EED093D-7673-1052-E053-F662850A9CEA","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-768C-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Gynecological Disorder","valueDescription":"Female Reproductive System Disorder","ValueMeaning":{"publicId":"3249729","version":"1","preferredName":"Female Reproductive System Disorder","longName":"3249729","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the female genital system. Representative examples of non-neoplastic disorders include infection, endometriosis, and adenomyosis. Representative examples of neoplastic disorders include germ cell tumors, carcinoma, lymphoma, and sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Female Reproductive System Disorder","conceptCode":"C27020","definition":"A non-neoplastic or neoplastic disorder that affects the female genital system. Representative examples of non-neoplastic disorders include infection, endometriosis, and adenomyosis. Representative examples of neoplastic disorders include germ cell tumors, carcinoma, lymphoma, and sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-3851-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EED093D-76A0-1052-E053-F662850A9CEA","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Cardiovascular Disease","valueDescription":"Cardiovascular Disorder","ValueMeaning":{"publicId":"2630208","version":"1","preferredName":"Cardiovascular Disorder","longName":"2630208","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels).  Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension.  Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C3390-BBE2-1B34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-20","modifiedBy":"COLBERTM","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B23F263-3442-0A59-E053-F662850A6261","beginDate":"2019-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-12","modifiedBy":"ONEDATA","dateModified":"2019-06-12","deletedIndicator":"No"},{"value":"Perinatal Depression","valueDescription":"Perinatal Depression","ValueMeaning":{"publicId":"6833151","version":"1","preferredName":"Perinatal Depression","longName":"6833151","preferredDefinition":"A condition characterized by cardiorespiratory and neurological depression following birth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perinatal Depression","conceptCode":"C116313","definition":"A condition characterized by cardiorespiratory and neurological depression following birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9CBA14-DE81-04C3-E053-F662850AC436","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DE9C-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Peptic Ulcer","valueDescription":"Peptic Ulcer","ValueMeaning":{"publicId":"2573562","version":"1","preferredName":"Peptic Ulcer","longName":"2573562","preferredDefinition":"Ulcer that occurs in those portions of the alimentary tract which come into contact with gastric juice containing pepsin and acid. It occurs when the amount of acid and pepsin is sufficient to overcome the gastric mucosal barrier.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peptic Ulcer","conceptCode":"C3318","definition":"A mucosal erosion that occurs in the esophagus, stomach or duodenum. Symptoms can include abdominal pain, nausea and vomiting, and bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC67-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DEA6-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Parkinson's Disease","valueDescription":"Parkinson's Disease","ValueMeaning":{"publicId":"3604284","version":"1","preferredName":"Parkinson's Disease","longName":"3604284","preferredDefinition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson Disease","conceptCode":"C26845","definition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B91F-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DEB1-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Paratyphoid Fever","valueDescription":"Paratyphoid Fever","ValueMeaning":{"publicId":"6833153","version":"1","preferredName":"Paratyphoid Fever","longName":"6833153","preferredDefinition":"A condition resembling typhoid fever that is caused by infection by Salmonella enterica serovar Parathyphi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paratyphoid Fever","conceptCode":"C34897","definition":"A condition resembling typhoid fever that is caused by infection by Salmonella enterica serovar Parathyphi.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9CBA14-DEBE-04C3-E053-F662850AC436","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DED7-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Paralytic Ileus","valueDescription":"Paralytic Ileus","ValueMeaning":{"publicId":"6833155","version":"1","preferredName":"Paralytic Ileus","longName":"6833155","preferredDefinition":"An ileus caused by abdominal or pelvic surgery, infections, disorders that affect the muscles and nerves, and medications.  Signs and symptoms include those of intestinal obstruction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paralytic Ileus","conceptCode":"C93045","definition":"An ileus caused by abdominal or pelvic surgery, infections, disorders that affect the muscles and nerves, and medications.  Signs and symptoms include those of intestinal obstruction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9CBA14-DEE4-04C3-E053-F662850AC436","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DEFD-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Pancreatitis","valueDescription":"Pancreatitis","ValueMeaning":{"publicId":"2946003","version":"1","preferredName":"Pancreatitis","longName":"2946003","preferredDefinition":"Inflammation of the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatitis","conceptCode":"C3306","definition":"Inflammation of the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-41F3-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF07-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Pancreatic Carcinoma","valueDescription":"Pancreatic Carcinoma","ValueMeaning":{"publicId":"2672905","version":"1","preferredName":"Pancreatic Carcinoma","longName":"2672905","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A62B-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF12-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Otitis Media","valueDescription":"Otitis Media","ValueMeaning":{"publicId":"2945731","version":"1","preferredName":"Otitis Media","longName":"2945731","preferredDefinition":"An acute or chronic inflammatory process affecting the middle ear.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Otitis Media","conceptCode":"C34885","definition":"Inflammation of the anatomical structures of the middle ear, which is most often caused by an infectious process. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-4BF5-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF26-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Oropharyngeal Carcinoma","valueDescription":"Oropharyngeal Carcinoma","ValueMeaning":{"publicId":"2683233","version":"1","preferredName":"Oropharyngeal Carcinoma","longName":"2683233","preferredDefinition":"Carcinoma, predominantly squamous cell, arising from epithelial cells of the oropharynx. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal Carcinoma","conceptCode":"C9105","definition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A83FCB0-9D0F-2594-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-19","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF31-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Oral Cavity Carcinoma","valueDescription":"Oral Cavity Carcinoma","ValueMeaning":{"publicId":"3813823","version":"1","preferredName":"Oral Cavity Carcinoma","longName":"3813823","preferredDefinition":"Cancer that forms in tissues of the oral cavity (the mouth). The tissues of the oral cavity include the lips, the lining inside the cheeks and lips, the front two thirds of the tongue, the upper and lower gums, the floor of the mouth under the tongue, the bony roof of the mouth, and the small area behind the wisdom teeth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Cavity Carcinoma","conceptCode":"C8990","definition":"A carcinoma arising in the oral cavity.  Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums.  Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2346CC1-C211-646B-E040-BB89AD434597","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF3B-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Nutritional Disorder","valueDescription":"Nutritional Disorder","ValueMeaning":{"publicId":"6660965","version":"1","preferredName":"Nutritional Disorder","longName":"6660965","preferredDefinition":"Any condition related to a disturbance between proper intake and utilization of nourishment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nutritional Disorder","conceptCode":"C26836","definition":"Any condition related to a disturbance between proper intake and utilization of nourishment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C16F-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF45-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Non-infective Inflammatory Bowel Disease","valueDescription":"Non-infective Inflammatory Bowel Disease","ValueMeaning":{"publicId":"6833157","version":"1","preferredName":"Non-infective Inflammatory Bowel Disease","longName":"6833157","preferredDefinition":"A disease of the intestines that is inflammatory but not infectious.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-infective Inflammatory Bowel Disease","conceptCode":"C157936","definition":"A disease of the intestines that is inflammatory but not infectious.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9CBA14-DF53-04C3-E053-F662850AC436","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CBA14-DF6C-04C3-E053-F662850AC436","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Pharyngeal Carcinoma","valueDescription":"Pharyngeal Carcinoma","ValueMeaning":{"publicId":"6832320","version":"1","preferredName":"Pharyngeal Carcinoma","longName":"6832320","preferredDefinition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the pharynx.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharyngeal Carcinoma","conceptCode":"C9466","definition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the pharynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E98BD11-EA73-319D-E053-F662850A9BD2","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9CC051-176E-61D7-E053-F662850AB475","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Psychiatric Disorder","valueDescription":"Psychiatric Disorder","ValueMeaning":{"publicId":"2578553","version":"1","preferredName":"Psychiatric Disorder","longName":"2578553","preferredDefinition":"Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Psychiatric Disorder","conceptCode":"C2893","definition":"A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFE6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"REEVESD","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9A76BA-9F48-69B5-E053-F662850AA843","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Protein Energy Malnutrition","valueDescription":"Protein Energy Malnutrition","ValueMeaning":{"publicId":"6833364","version":"1","preferredName":"Protein Energy Malnutrition","longName":"6833364","preferredDefinition":"A nutritional deficit that is caused by inadequate protein or calorie intake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Energy Malnutrition","conceptCode":"C34952","definition":"A nutritional deficit that is caused by inadequate protein or calorie intake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9A76BA-9F56-69B5-E053-F662850AA843","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9A76BA-9F6F-69B5-E053-F662850AA843","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Prostate Carcinoma","valueDescription":"Prostate Carcinoma","ValueMeaning":{"publicId":"5581340","version":"1","preferredName":"Prostate Carcinoma","longName":"5581340","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B85C-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E9A76BA-9F79-69B5-E053-F662850AA843","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","deletedIndicator":"No"},{"value":"Tracheal Carcinoma","valueDescription":"Tracheal Carcinoma","ValueMeaning":{"publicId":"6834700","version":"1","preferredName":"Tracheal Carcinoma","longName":"6834700","preferredDefinition":"Malignant epithelial neoplasm arising from the tracheal mucosa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tracheal Carcinoma","conceptCode":"C9347","definition":"Malignant epithelial neoplasm arising from the tracheal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFA9C9-856A-695C-E053-F662850A6B91","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-8585-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Thyroid Gland Carcinoma","valueDescription":"Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"5581344","version":"1","preferredName":"Thyroid Gland Carcinoma","longName":"5581344","preferredDefinition":"A carcinoma arising from the thyroid gland. It is usually an adenocarcinoma and includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8E8-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-858F-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Thalassemia","valueDescription":"Thalassemia","ValueMeaning":{"publicId":"2593293","version":"1","preferredName":"Thalassemia","longName":"2593293","preferredDefinition":"A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thalassemia","conceptCode":"C35069","definition":"An inherited blood disorder characterized by a decreased synthesis of one of the polypeptide chains that form hemoglobin. Anemia results from this abnormal hemoglobin formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28821A33-CC97-19A3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-8599-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Tetanus","valueDescription":"Tetanus","ValueMeaning":{"publicId":"3211476","version":"1","preferredName":"Tetanus","longName":"3211476","preferredDefinition":"A serious infectious disorder that follows wound contamination by the Gram-positive bacterium Clostridium tetani. The bacteria produce a neurotoxin called tetanospasmin, which causes muscle spasm in the jaw and other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tetanus","conceptCode":"C85185","definition":"A serious infectious disorder that follows wound contamination by the Gram-positive bacterium Clostridium tetani. The bacteria produce a neurotoxin called tetanospasmin, which causes muscle spasm in the jaw and other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0395-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-85A4-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Syphilis","valueDescription":"Syphilis","ValueMeaning":{"publicId":"2577420","version":"1","preferredName":"Syphilis","longName":"2577420","preferredDefinition":"A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Syphilis","conceptCode":"C35055","definition":"A contagious bacterial infection caused by the spirochete Treponema pallidum. It is a sexually transmitted disorder, although it can also be transmitted from the mother to the fetus in utero. Typically, it is initially manifested with a single sore which heals without treatment. If the infection is left untreated, the initial stage is followed by skin rash and mucous membrane lesions. A late stage follows, which is characterized by damage of the internal organs, including the nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FB79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-01-18","modifiedBy":"ONEDATA","dateModified":"2006-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-85AF-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Skin Disorder","valueDescription":"Skin Disorder","ValueMeaning":{"publicId":"2573576","version":"1","preferredName":"Skin Disorder","longName":"2573576","preferredDefinition":"Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Disorder","conceptCode":"C3371","definition":"Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC75-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-85BA-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Skin Carcinoma","valueDescription":"Skin Carcinoma","ValueMeaning":{"publicId":"3935812","version":"1","preferredName":"Skin Carcinoma","longName":"3935812","preferredDefinition":"Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Carcinoma","conceptCode":"C4914","definition":"A carcinoma that arises from the skin.  Representative examples are basal cell carcinoma and squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9D24C44-E3A5-94AD-E040-BB89AD43540A","latestVersionIndicator":"Yes","beginDate":"2013-10-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFA9C9-85C5-695C-E053-F662850A6B91","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Urinary System Disorder","valueDescription":"Urinary Tract Disorder","ValueMeaning":{"publicId":"2578554","version":"1","preferredName":"Urinary Tract Disorder","longName":"2578554","preferredDefinition":"Disorders of any part of the urologic system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urinary System Disorder","conceptCode":"C3430","definition":"A non-neoplastic or neoplastic disorder affecting the urinary system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"ONEDATA","dateModified":"2006-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFC43E-5826-7F3E-E053-F662850A29E0","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Upper Respiratory Tract Infection","valueDescription":"Upper Respiratory Tract Infection","ValueMeaning":{"publicId":"2944013","version":"1","preferredName":"Upper Respiratory Tract Infection","longName":"2944013","preferredDefinition":"An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Respiratory Tract Infection","conceptCode":"C35650","definition":"An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-120B-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFC43E-5831-7F3E-E053-F662850A29E0","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Typhoid Fever","valueDescription":"Typhoid Fever","ValueMeaning":{"publicId":"6834704","version":"1","preferredName":"Typhoid Fever","longName":"6834704","preferredDefinition":"A bacterial infectious disorder contracted by consumption of food or drink contaminated with Salmonella typhi. This disorder is common in developing countries and can be treated with antibiotics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Typhoid Fever","conceptCode":"C35089","definition":"A bacterial infectious disorder contracted by consumption of food or drink contaminated with Salmonella typhi. This disorder is common in developing countries and can be treated with antibiotics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFC43E-583F-7F3E-E053-F662850A29E0","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFC43E-5858-7F3E-E053-F662850A29E0","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Tuberculosis","valueDescription":"Tuberculosis","ValueMeaning":{"publicId":"5427583","version":"1","preferredName":"Tuberculosis","longName":"5427583","preferredDefinition":"A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tuberculosis","conceptCode":"C3423","definition":"A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E8CEE-1054-EC88-E050-BB89AD432072","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFC43E-5862-7F3E-E053-F662850A29E0","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Tropical Disease","valueDescription":"Tropical Disease","ValueMeaning":{"publicId":"6834706","version":"1","preferredName":"Tropical Disease","longName":"6834706","preferredDefinition":"Infectious and parasitic diseases endemic in tropical and subtropical zones, including Chagas' disease, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, sleeping sickness, yellow fever, and others; often water- or insect-borne.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tropical Disease","conceptCode":"C28356","definition":"Infectious and parasitic diseases endemic in tropical and subtropical zones, including Chagas' disease, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, sleeping sickness, yellow fever, and others; often water- or insect-borne.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EBFC43E-5870-7F3E-E053-F662850A29E0","latestVersionIndicator":"Yes","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFC43E-5889-7F3E-E053-F662850A29E0","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Sickle Cell Disease","valueDescription":"Sickle Cell Disease","ValueMeaning":{"publicId":"3301976","version":"1","preferredName":"Sickle Cell Disease","longName":"3301976","preferredDefinition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFDE-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBF738A-7893-7F3A-E053-F662850AAC7D","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Sexually Transmitted Disorder","valueDescription":"Sexually Transmitted Disorder","ValueMeaning":{"publicId":"4395682","version":"1","preferredName":"Sexually Transmitted Disorder","longName":"4395682","preferredDefinition":"A disorder acquired through sexual contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sexually Transmitted Disorder","conceptCode":"C3365","definition":"A disorder acquired through sexual contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB7F5B9-30FA-D31B-E040-BB89AD436814","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBF738A-789E-7F3A-E053-F662850AAC7D","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Whooping Cough","valueDescription":"Whooping Cough","ValueMeaning":{"publicId":"3211528","version":"1","preferredName":"Whooping Cough","longName":"3211528","preferredDefinition":"A contagious bacterial respiratory infection caused by Bordetella pertussis. It is characterized by severe and uncontrollable cough, resulting in a whooping sound during breathing following the cough.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Whooping Cough","conceptCode":"C85231","definition":"A contagious bacterial respiratory infection caused by Bordetella pertussis. It is characterized by severe and uncontrollable cough, resulting in a whooping sound during breathing following the cough.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0B25-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EBFDCF0-EB59-6920-E053-F662850ADAC0","beginDate":"2019-07-28","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-28","modifiedBy":"ONEDATA","dateModified":"2019-07-28","deletedIndicator":"No"},{"value":"Hemoglobinopathy","valueDescription":"Hemoglobinopathy","ValueMeaning":{"publicId":"2593295","version":"1","preferredName":"Hemoglobinopathy","longName":"2593295","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28821A9F-371A-19B1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-58BC-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hemolytic Anemia","valueDescription":"Hemolytic Anemia","ValueMeaning":{"publicId":"4395757","version":"1","preferredName":"Hemolytic Anemia","longName":"4395757","preferredDefinition":"Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemolytic Anemia","conceptCode":"C34376","definition":"Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D76B-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-58C7-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hemorrhagic Cerebrovascular Accident","valueDescription":"Hemorrhagic Cerebrovascular Accident","ValueMeaning":{"publicId":"6425114","version":"1","preferredName":"Hemorrhagic Cerebrovascular Accident","longName":"6425114","preferredDefinition":"An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhagic Stroke","conceptCode":"C95803","definition":"An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7535C691-E408-0560-E053-F662850A6A22","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-06","modifiedBy":"ONEDATA","dateModified":"2018-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-58DC-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":"Hepatitis","ValueMeaning":{"publicId":"3257061","version":"1","preferredName":"Hepatitis","longName":"3257061","preferredDefinition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AA35B8-AD6E-E3A8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2011-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-58E7-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hepatitis A Infection","valueDescription":"Hepatitis A","ValueMeaning":{"publicId":"2567486","version":"1","preferredName":"Hepatitis A","longName":"2567486","preferredDefinition":"Hepatitis caused by HEPATOVIRUS. It can be transmitted through fecal contamination of food or water.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis A Infection","conceptCode":"C3096","definition":"Acute inflammation of the liver caused by the hepatitis A virus. It is highly contagious and usually contracted through close contact with an infected individual or their feces, contaminated food or water.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4AB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-58F4-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hepatitis B Virus-Related Hepatocellular Carcinoma","valueDescription":"Hepatitis B Virus-Related Hepatocellular Carcinoma","ValueMeaning":{"publicId":"6841438","version":"1","preferredName":"Hepatitis B Virus-Related Hepatocellular Carcinoma","longName":"6841438","preferredDefinition":"A hepatocellular carcinoma that develops following hepatitis B virus exposure and injury of the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus-Related Hepatocellular Carcinoma","conceptCode":"C27687","definition":"A hepatocellular carcinoma that develops following hepatitis B virus exposure and injury of the liver parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-5902-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-591D-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hepatitis C Virus-Related Hepatocellular Carcinoma","valueDescription":"Hepatitis C Virus-Related Hepatocellular Carcinoma","ValueMeaning":{"publicId":"6841440","version":"1","preferredName":"Hepatitis C Virus-Related Hepatocellular Carcinoma","longName":"6841440","preferredDefinition":"A hepatocellular carcinoma that develops following hepatitis C virus exposure and injury of the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Virus-Related Hepatocellular Carcinoma","conceptCode":"C27688","definition":"A hepatocellular carcinoma that develops following hepatitis C virus exposure and injury of the liver parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-592A-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5945-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hodgkin Lymphoma","valueDescription":"Hodgkin Lymphoma","ValueMeaning":{"publicId":"4981811","version":"1","preferredName":"Hodgkin Lymphoma","longName":"4981811","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of large tumor cells in an abundant admixture of nonneoplastic cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E139787-9898-E8CC-E050-BB89AD435F1A","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-594F-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Hypertension-Associated Pregnancy Disorder","valueDescription":"Hypertension-Associated Pregnancy Disorder","ValueMeaning":{"publicId":"6841443","version":"1","preferredName":"Hypertension-Associated Pregnancy Disorder","longName":"6841443","preferredDefinition":"A hypertensive disorder that develops during pregnancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension-Associated Pregnancy Disorder","conceptCode":"C9243","definition":"A hypertensive disorder that develops during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-595C-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5977-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Immune System Disorder","valueDescription":"Immune System Disorder","ValueMeaning":{"publicId":"2578546","version":"1","preferredName":"Immune System Disorder","longName":"2578546","preferredDefinition":"A disorder resulting from an abnormality in the immune system. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System Disorder","conceptCode":"C3507","definition":"A disorder resulting from an abnormality in the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFDF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"ONEDATA","dateModified":"2006-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5982-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Impetigo","valueDescription":"Impetigo","ValueMeaning":{"publicId":"3309124","version":"1","preferredName":"Impetigo","longName":"3309124","preferredDefinition":"A contagious bacterial cutaneous infection that affects children and is usually caused by Staphylococcus aureus. It usually presents in the face with honey colored scabs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Impetigo","conceptCode":"C99088","definition":"A contagious bacterial cutaneous infection that affects children and is usually caused by Staphylococcus aureus. It usually presents in the face with honey colored scabs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2696424-34B8-40DD-E040-BB89AD435496","latestVersionIndicator":"Yes","beginDate":"2011-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-598D-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Infectious Disease","valueDescription":"Infectious Disorder","ValueMeaning":{"publicId":"4824551","version":"1","preferredName":"Infectious Disorder","longName":"4824551","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15F5F0DF-BD14-EF20-E050-BB89AD431CD6","latestVersionIndicator":"Yes","beginDate":"2015-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-05-13","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-59A2-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Infertility","valueDescription":"Infertility","ValueMeaning":{"publicId":"6841444","version":"1","preferredName":"Infertility","longName":"6841444","preferredDefinition":"The inability to produce children.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infertility","conceptCode":"C3836","definition":"Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-59AD-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-59C8-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Influenza","valueDescription":"Influenza","ValueMeaning":{"publicId":"3604288","version":"1","preferredName":"Influenza","longName":"3604288","preferredDefinition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza","conceptCode":"C53482","definition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B9AD-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-59D2-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Inguinal Hernia","valueDescription":"Inguinal Hernia","ValueMeaning":{"publicId":"6841446","version":"1","preferredName":"Inguinal Hernia","longName":"6841446","preferredDefinition":"The protrusion of a sac-like structure containing fibroadipose tissue through an abnormal opening in the inguinal region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inguinal Hernia","conceptCode":"C34690","definition":"The protrusion of a sac-like structure containing fibroadipose tissue through an abnormal opening in the inguinal region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-59DF-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-59F8-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Interstitial Nephritis","valueDescription":"Interstitial Nephritis","ValueMeaning":{"publicId":"3252172","version":"1","preferredName":"Interstitial Nephritis","longName":"3252172","preferredDefinition":"Diffuse or local inflammation and edema of the interstitial tissue of the kidney, including the tubules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interstitial Nephritis","conceptCode":"C26834","definition":"Inflammation of the renal tubules and supporting tissues of the kidney.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A78372C6-E3DE-4779-E040-BB89AD432A7F","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5A0C-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Interstitial Pneumonia","valueDescription":"Interstitial Pneumonia","ValueMeaning":{"publicId":"6841447","version":"1","preferredName":"Interstitial Pneumonia","longName":"6841447","preferredDefinition":"Inflammation of interstitial lung tissue, usually associated with infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-5A19-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5A32-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Iron-Deficiency Anemia","valueDescription":"Iron-Deficiency Anemia","ValueMeaning":{"publicId":"3210749","version":"1","preferredName":"Iron-Deficiency Anemia","longName":"3210749","preferredDefinition":"Anemia caused by low iron intake, inefficient iron absorption in the gastrointestinal tract, or chronic blood loss.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron-Deficiency Anemia","conceptCode":"C84484","definition":"Anemia caused by low iron intake, inefficient iron absorption in the gastrointestinal tract, or chronic blood loss.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-996E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5A3C-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Ischemic Cerebrovascular Accident","valueDescription":"Ischemic Cerebrovascular Accident","ValueMeaning":{"publicId":"3236724","version":"1","preferredName":"Ischemic Cerebrovascular Accident","longName":"3236724","preferredDefinition":"A sudden loss of neurological function secondary to ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ischemic Stroke","conceptCode":"C95802","definition":"An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3BC4428-F110-7327-E040-BB89AD4301BA","latestVersionIndicator":"Yes","beginDate":"2011-05-20","endDate":null,"createdBy":"LUY","dateCreated":"2011-05-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5A53-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Ischemic Heart Disease","valueDescription":"Ischemic Heart Disease","ValueMeaning":{"publicId":"3248585","version":"1","preferredName":"Ischemic Heart Disease","longName":"3248585","preferredDefinition":"A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries, to obstruction by a thrombus, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ischemic Heart Disease","conceptCode":"C50625","definition":"A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries, to obstruction by a thrombus, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-C06E-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5A67-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Kidney Carcinoma","valueDescription":"Kidney Carcinoma","ValueMeaning":{"publicId":"5581334","version":"1","preferredName":"Kidney Carcinoma","longName":"5581334","preferredDefinition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Carcinoma","conceptCode":"C9384","definition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B77F-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDB21B-5A71-25F6-E053-F662850A7B8E","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Laryngeal Carcinoma","valueDescription":"Laryngeal Carcinoma","ValueMeaning":{"publicId":"3813819","version":"1","preferredName":"Laryngeal Carcinoma","longName":"3813819","preferredDefinition":"Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal carcinomas are squamous cell carcinomas. The remainder are adenoid cystic carcinomas, mucoepidermoid carcinomas and carcinomas with neuroendocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laryngeal Carcinoma","conceptCode":"C4855","definition":"Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal carcinomas are squamous cell carcinomas. The remainder are adenoid cystic carcinomas, mucoepidermoid carcinomas and carcinomas with neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2346CC1-C1AB-646B-E040-BB89AD434597","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8EAE-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Leishmaniasis","valueDescription":"Leishmaniasis","ValueMeaning":{"publicId":"3211217","version":"1","preferredName":"Leishmaniasis","longName":"3211217","preferredDefinition":"A parasitic infection caused by protozoa of the genus Leishmania. It is transmitted to humans via the bite of sandflies. There are three main forms of the disease: cutaneous, mucocutaneous, and visceral leishmaniasis. Cutaneous leishmaniasis causes skin ulcers; mucocutaneous leishmaniasis causes destructive lesions of the mucous membranes of the nose, mouth, and throat; visceral leishmaniasis is the most severe form of the disease and is manifested with anemia, weight loss, hepatomegaly and splenomegaly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leishmaniasis","conceptCode":"C34767","definition":"A parasitic infection caused by protozoa of the genus Leishmania. It is transmitted to humans via the bite of sandflies. There are three main forms of the disease: cutaneous, mucocutaneous, and visceral leishmaniasis. Cutaneous leishmaniasis causes skin ulcers; mucocutaneous leishmaniasis causes destructive lesions of the mucous membranes of the nose, mouth, and throat; visceral leishmaniasis is the most severe form of the disease and is manifested with anemia, weight loss, hepatomegaly and splenomegaly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DE51-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8EB8-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Leukemia","valueDescription":"Leukemia","ValueMeaning":{"publicId":"3179697","version":"1","preferredName":"Leukemia","longName":"3179697","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F258D4-9F60-3E56-E040-BB89AD436715","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8EC3-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Liver and Intrahepatic Bile Duct Carcinoma","valueDescription":"Liver and Intrahepatic Bile Duct Carcinoma","ValueMeaning":{"publicId":"5581335","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Carcinoma","longName":"5581335","preferredDefinition":"Primary liver cancer is cancer that forms in the tissues of the liver. Secondary liver cancer is cancer that spreads to the liver from another part of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver and Intrahepatic Bile Duct Carcinoma","conceptCode":"C7927","definition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8ECD-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Liver and Intrahepatic Bile Duct Disorder","valueDescription":"Liver and Intrahepatic Bile Duct Disorder","ValueMeaning":{"publicId":"4827921","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Disorder","longName":"4827921","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and polycystic liver disease. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, lymphoma, and angiosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver and Intrahepatic Bile Duct Disorder","conceptCode":"C3196","definition":"A non-neoplastic or neoplastic disorder that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and polycystic liver disease. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, lymphoma, and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F249-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8EE1-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Liver Fluke Infestation","valueDescription":"Schistosomiasis","ValueMeaning":{"publicId":"3211429","version":"1","preferredName":"Schistosomiasis","longName":"3211429","preferredDefinition":"A parasitic infection caused by flukes of the genus Schistosoma. Signs and symptoms include fever, abdominal pain, eosinophilia and hepatosplenomegaly. If left untreated it may eventually cause liver damage leading to cirrhosis, bladder cancer and kidney failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schistosomiasis","conceptCode":"C35000","definition":"A parasitic infection caused by flukes of the genus Schistosoma. Signs and symptoms include fever, abdominal pain, eosinophilia and hepatosplenomegaly. If left untreated it may eventually cause liver damage leading to cirrhosis, bladder cancer and kidney failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FC87-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8EF6-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Lower Respiratory Tract Infection","valueDescription":"Lower Respiratory Tract Infection","ValueMeaning":{"publicId":"6841449","version":"1","preferredName":"Lower Respiratory Tract Infection","longName":"6841449","preferredDefinition":"An acute or chronic, viral or bacterial infectious process that affects the lower respiratory tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lower Respiratory Tract Infection","conceptCode":"C35158","definition":"An acute or chronic, viral or bacterial infectious process that affects the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDEB13-8F04-5D08-E053-F662850A1146","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F1F-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Lung Carcinoma","valueDescription":"Lung Carcinoma","ValueMeaning":{"publicId":"5581336","version":"1","preferredName":"Lung Carcinoma","longName":"5581336","preferredDefinition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F29-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Malaria","valueDescription":"Malaria (Plasmodium)","ValueMeaning":{"publicId":"3211236","version":"1","preferredName":"Malaria (Plasmodium)","longName":"3211236","preferredDefinition":"A protozoan infection caused by the genus Plasmodium. There are four species of Plasmodium that can infect humans: Plasmodium falciparum, vivax, ovale, and malariae. It is transmitted to humans by infected mosquitoes. Signs and symptoms include paroxysmal high fever, sweating, chills, and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malaria","conceptCode":"C34797","definition":"A protozoan infection caused by the genus Plasmodium. There are four species of Plasmodium that can infect humans: Plasmodium falciparum, vivax, ovale, and malariae. It is transmitted to humans by infected mosquitoes. Signs and symptoms include paroxysmal high fever, sweating, chills, and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E0EB-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F33-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Malignant Brain Neoplasm","valueDescription":"Malignant Brain Neoplasm","ValueMeaning":{"publicId":"5581328","version":"1","preferredName":"Malignant Brain Neoplasm","longName":"5581328","preferredDefinition":"A primary or metastatic malignant neoplasm affecting the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Brain Neoplasm","conceptCode":"C3568","definition":"A primary or metastatic malignant neoplasm affecting the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6AD-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F3E-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Malignant Ovarian Neoplasm","valueDescription":"Malignant Ovarian Neoplasm","ValueMeaning":{"publicId":"3210710","version":"1","preferredName":"Malignant Ovarian Neoplasm","longName":"3210710","preferredDefinition":"A primary or metastatic malignant tumor involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Ovarian Neoplasm","conceptCode":"C7431","definition":"A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9248-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F48-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Malignant Testicular Neoplasm","valueDescription":"Malignant Testicular Neoplasm","ValueMeaning":{"publicId":"5581347","version":"1","preferredName":"Malignant Testicular Neoplasm","longName":"5581347","preferredDefinition":"A primary or metastatic malignant neoplasm that affects the testis.  Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Neoplasm","conceptCode":"C7251","definition":"A primary or metastatic malignant neoplasm that affects the testis.  Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B951-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F52-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Malignant Urinary System Neoplasm","valueDescription":"Malignant Urinary System Neoplasm","ValueMeaning":{"publicId":"4722496","version":"1","preferredName":"Malignant Urinary System Neoplasm","longName":"4722496","preferredDefinition":"A primary or metastatic malignant tumor involving the urinary system.  Common tumor types include carcinomas, lymphomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Urinary System Neoplasm","conceptCode":"C9297","definition":"A primary or metastatic malignant neoplasm involving the urinary system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8748A7-474D-DF2B-E050-BB89AD4311E0","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F5C-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Malignant Uterine Neoplasm","valueDescription":"Malignant Uterine Neoplasm","ValueMeaning":{"publicId":"5581345","version":"1","preferredName":"Malignant Uterine Neoplasm","longName":"5581345","preferredDefinition":"Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Uterine Neoplasm","conceptCode":"C3552","definition":"Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B90B-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F66-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Maternal Complication of Pregnancy","valueDescription":"Maternal Complication of Pregnancy","ValueMeaning":{"publicId":"6841450","version":"1","preferredName":"Maternal Complication of Pregnancy","longName":"6841450","preferredDefinition":"The development of a problematic medical situation that occurs during pregnancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maternal Complication of Pregnancy","conceptCode":"C35594","definition":"The development of a problematic medical situation that occurs during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDEB13-8F70-5D08-E053-F662850A1146","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEDEB13-8F8B-5D08-E053-F662850A1146","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Measles","valueDescription":"Measles","ValueMeaning":{"publicId":"6841452","version":"1","preferredName":"Measles","longName":"6841452","preferredDefinition":"A highly contagious viral infection caused by the measles virus. Symptoms appear 8-12 days after exposure and include a rash, cough, fever and muscle pains that can last 4-7 days. Measles vaccines are available to provide prophylaxis, usually combined with mumps and rubella vaccines (MMR).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measles","conceptCode":"C96406","definition":"A highly contagious viral infection caused by the measles virus. Symptoms appear 8-12 days after exposure and include a rash, cough, fever and muscle pains that can last 4-7 days. Measles vaccines are available to provide prophylaxis, usually combined with mumps and rubella vaccines (MMR).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEE049D-0F06-683F-E053-F662850AAEBC","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F1F-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Meningitis","valueDescription":"Meningitis","ValueMeaning":{"publicId":"5296502","version":"1","preferredName":"Meningitis","longName":"5296502","preferredDefinition":"A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningitis","conceptCode":"C26828","definition":"A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"355DBE29-8DDE-7C94-E050-BB89AD431EEF","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F2B-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Multiple Sclerosis","valueDescription":"Multiple Sclerosis","ValueMeaning":{"publicId":"2760060","version":"1","preferredName":"Multiple Sclerosis","longName":"2760060","preferredDefinition":"A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body's immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis","conceptCode":"C3243","definition":"A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FE4369C-D09F-4E65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F36-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Musculoskeletal System Disorder","valueDescription":"Musculoskeletal System Disorder","ValueMeaning":{"publicId":"6143235","version":"1","preferredName":"Musculoskeletal System Disorder","longName":"6143235","preferredDefinition":"A category of diseases that involve muscles and bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Musculoskeletal Disorder","conceptCode":"C107377","definition":"A non-neoplastic or neoplastic disorder that affects muscles and bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67DC7A0C-1EDB-2C62-E053-F662850A6D0F","latestVersionIndicator":"Yes","beginDate":"2018-03-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-20","modifiedBy":"ONEDATA","dateModified":"2018-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F4C-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Mycobacterial Infection","valueDescription":"Mycobacterial Infection","ValueMeaning":{"publicId":"3250516","version":"1","preferredName":"Mycobacterial Infection","longName":"3250516","preferredDefinition":"Infections with bacteria of the genus MYCOBACTERIUM.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mycobacterial Infection","conceptCode":"C26831","definition":"Infection due to organisms from the genus Mycobacteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C880-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F61-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Myocarditis","valueDescription":"Myocarditis","ValueMeaning":{"publicId":"2946008","version":"1","preferredName":"Myocarditis","longName":"2946008","preferredDefinition":"Inflammation of the muscle tissue of the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocarditis","conceptCode":"C34831","definition":"Inflammation of the muscle tissue of the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-42A3-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F6C-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Nasopharyngeal Carcinoma","valueDescription":"Nasopharyngeal Carcinoma","ValueMeaning":{"publicId":"4264956","version":"1","preferredName":"Nasopharyngeal Carcinoma","longName":"4264956","preferredDefinition":"A carcinoma arising from the nasopharyngeal epithelium.  It includes the following types: keratinizing squamous cell carcinoma, nonkeratinizing carcinoma (differentiated and undifferentiated), basaloid squamous cell carcinoma, and papillary adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Carcinoma","conceptCode":"C3871","definition":"A carcinoma arising from the nasopharyngeal epithelium.  It includes the following types: keratinizing squamous cell carcinoma, nonkeratinizing carcinoma (differentiated and undifferentiated), basaloid squamous cell carcinoma, and papillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3A91-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F77-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neonatal Disorder","valueDescription":"Neonatal Disorder","ValueMeaning":{"publicId":"6841454","version":"1","preferredName":"Neonatal Disorder","longName":"6841454","preferredDefinition":"A non-neoplastic or neoplastic disorder which occurs during the neonatal period.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neonatal Disorder","conceptCode":"C98996","definition":"A non-neoplastic or neoplastic disorder which occurs during the neonatal period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEE049D-0F84-683F-E053-F662850AAEBC","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0F9D-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neonatal Encephalopathy","valueDescription":"Neonatal Encephalopathy","ValueMeaning":{"publicId":"6841456","version":"1","preferredName":"Neonatal Encephalopathy","longName":"6841456","preferredDefinition":"Abnormal functioning of the central nervous system in the newborn period that may be due to a variety of etiologies including hypoxia/ischemia, metabolic disturbance, or infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neonatal Encephalopathy","conceptCode":"C119758","definition":"Abnormal functioning of the central nervous system in the newborn period that may be due to a variety of etiologies including hypoxia/ischemia, metabolic disturbance, or infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEE049D-0FAA-683F-E053-F662850AAEBC","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0FC3-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neonatal Infectious Disorder","valueDescription":"Neonatal Infectious Disorder","ValueMeaning":{"publicId":"6841458","version":"1","preferredName":"Neonatal Infectious Disorder","longName":"6841458","preferredDefinition":"An infectious disorder that occurs during the neonatal period. Representative examples include streptococcal infection, E.coli infection, and bacterial meningitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neonatal Infectious Disorder","conceptCode":"C99231","definition":"An infectious disorder that occurs during the neonatal period. Representative examples include streptococcal infection, E.coli infection, and bacterial meningitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEE049D-0FD0-683F-E053-F662850AAEBC","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-0FE9-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neonatal Injury Related to Birth","valueDescription":"Neonatal Injury Related to Birth","ValueMeaning":{"publicId":"6841460","version":"1","preferredName":"Neonatal Injury Related to Birth","longName":"6841460","preferredDefinition":"An injury sustained to a neonate during the birthing process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neonatal Injury Related to Birth","conceptCode":"C101035","definition":"An injury sustained to a neonate during the birthing process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEE049D-0FF6-683F-E053-F662850AAEBC","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-100F-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neonatal Sepsis","valueDescription":"Neonatal Sepsis","ValueMeaning":{"publicId":"6841462","version":"1","preferredName":"Neonatal Sepsis","longName":"6841462","preferredDefinition":"An infectious disorder of newborn infants that is characterized by a systemic inflammatory response most commonly caused by bacteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neonatal Sepsis","conceptCode":"C116802","definition":"An infectious disorder of newborn infants that is characterized by a systemic inflammatory response most commonly caused by bacteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEE049D-101C-683F-E053-F662850AAEBC","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-1035-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neoplasm","valueDescription":"Neoplasm","ValueMeaning":{"publicId":"3071117","version":"1","preferredName":"Neoplasm","longName":"3071117","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B019E9-7DC7-77A7-E040-BB89AD4330E0","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-103F-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Nervous System Disorder","valueDescription":"Nervous System Disorder","ValueMeaning":{"publicId":"2578551","version":"1","preferredName":"Nervous System Disorder","longName":"2578551","preferredDefinition":"Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nervous System Disorder","conceptCode":"C26835","definition":"A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-104B-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Nervous System Neoplasm","valueDescription":"Nervous System Neoplasm","ValueMeaning":{"publicId":"6835478","version":"1","preferredName":"Nervous System Neoplasm","longName":"6835478","preferredDefinition":"A benign or malignant, primary or metastatic neoplasm involving the central or peripheral nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nervous System Neoplasm","conceptCode":"C3268","definition":"A benign or malignant, primary or metastatic neoplasm involving the central or peripheral nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ED4B8E8-62DA-3184-E053-F662850A89A7","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-29","modifiedBy":"ONEDATA","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-1056-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Neural Tube Defect","valueDescription":"Neural Tube Defect","ValueMeaning":{"publicId":"3211295","version":"1","preferredName":"Neural Tube Defect","longName":"3211295","preferredDefinition":"A congenital defect characterized by failure of the neural tube to close completely; this results in the presence of openings in the brain or spinal cord. Examples of neural tube defects include encephalocele and spina bifida.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neural Tube Defect","conceptCode":"C84923","definition":"A congenital defect characterized by failure of the neural tube to close completely; this results in the presence of openings in the brain or spinal cord. Examples of neural tube defects include encephalocele and spina bifida.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E9AB-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-1060-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Non-Hodgkin Lymphoma","valueDescription":"Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"2965201","version":"1","preferredName":"Non-Hodgkin Lymphoma","longName":"2965201","preferredDefinition":"Distinct from Hodgkin's lymphoma both morphologically and biologically, NHL lymphoma is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss.  The clinical course varies according to the morphologic type.  NHL is clinically classified as indolent, aggressive, or having a variable clinical course.  NHL can be of B-or T-/NK-cell lineage. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Hodgkin Lymphoma","conceptCode":"C3211","definition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A391AEC-04F8-397F-E040-BB89AD430848","latestVersionIndicator":"Yes","beginDate":"2009-12-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EEE049D-1075-683F-E053-F662850AAEBC","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Venomous Animal Contact","valueDescription":"Venomous Animal Contact","ValueMeaning":{"publicId":"7049946","version":"1","preferredName":"Venomous Animal Contact","longName":"7049946","preferredDefinition":"Contact with a venomous animal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Venomous Animal Contact","conceptCode":"C158031","definition":"Contact with a venomous animal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-15E5-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-15FE-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Transport Injury","valueDescription":"Transport Injury","ValueMeaning":{"publicId":"7049948","version":"1","preferredName":"Transport Injury","longName":"7049948","preferredDefinition":"An injury to an individual during transport between or to/from departments or facilities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transport Injury","conceptCode":"C158022","definition":"An injury to an individual during transport between or to/from departments or facilities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-160B-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-1624-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Subcutaneous Disorder","valueDescription":"Subcutaneous Disorder","ValueMeaning":{"publicId":"7049950","version":"1","preferredName":"Subcutaneous Disorder","longName":"7049950","preferredDefinition":"A disorder of the subcutaneous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subcutaneous Disorder","conceptCode":"C157995","definition":"A disorder of the subcutaneous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-1631-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-164A-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Shigellosis","valueDescription":"Shigellosis","ValueMeaning":{"publicId":"7049952","version":"1","preferredName":"Shigellosis","longName":"7049952","preferredDefinition":"An intestinal disease cause by Shigella bacteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shigellosis","conceptCode":"C157978","definition":"An intestinal disease cause by Shigella bacteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-1657-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-1670-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Sexually Transmitted Chlamydial Disease","valueDescription":"Sexually Transmitted Chlamydial Disease","ValueMeaning":{"publicId":"7049954","version":"1","preferredName":"Sexually Transmitted Chlamydial Disease","longName":"7049954","preferredDefinition":"A chlamydial infection that was sexually transmitted.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sexually Transmitted Chlamydial Disease","conceptCode":"C157977","definition":"A chlamydial infection that was sexually transmitted.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-167D-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-1696-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Salmonellosis","valueDescription":"Salmonellosis","ValueMeaning":{"publicId":"7049956","version":"1","preferredName":"Salmonellosis","longName":"7049956","preferredDefinition":"An intestinal bacterial disease caused by Salmonella bacteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salmonellosis","conceptCode":"C157974","definition":"An intestinal bacterial disease caused by Salmonella bacteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-16A3-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-16BC-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Road Injury","valueDescription":"Road Injury","ValueMeaning":{"publicId":"7049958","version":"1","preferredName":"Road Injury","longName":"7049958","preferredDefinition":"An injury that occurs on a road or motor way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Road Injury","conceptCode":"C157972","definition":"An injury that occurs on a road or motor way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-16C9-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-16E2-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Respiratory Syncytial Virus Pneumonia","valueDescription":"Respiratory Syncytial Virus Pneumonia","ValueMeaning":{"publicId":"7049960","version":"1","preferredName":"Respiratory Syncytial Virus Pneumonia","longName":"7049960","preferredDefinition":"Pneumonia that is attributed to the respiratory syncytial virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory Syncytial Virus Pneumonia","conceptCode":"C157971","definition":"Pneumonia that is attributed to the respiratory syncytial virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-16EF-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-1708-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Preterm Birth Complication","valueDescription":"Preterm Birth Complication","ValueMeaning":{"publicId":"7049962","version":"1","preferredName":"Preterm Birth Complication","longName":"7049962","preferredDefinition":"A complication related to a premature birth that occurs to a baby born prior to 37 weeks gestation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preterm Birth Complication","conceptCode":"C157961","definition":"A complication related to a premature birth that occurs to a baby born prior to 37 weeks gestation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-1715-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-172E-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Pneumococcal Pneumonia","valueDescription":"Pneumococcal Pneumonia","ValueMeaning":{"publicId":"7049964","version":"1","preferredName":"Pneumococcal Pneumonia","longName":"7049964","preferredDefinition":"Pneumonia that is attributed to the bacteria Streptococcus pneumonia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumococcal Pneumonia","conceptCode":"C157959","definition":"Pneumonia that is attributed to the bacteria Streptococcus pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-173B-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-1754-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Opiod Use Disorder","valueDescription":"Opiod Use Disorder","ValueMeaning":{"publicId":"7049968","version":"1","preferredName":"Opiod Use Disorder","longName":"7049968","preferredDefinition":"The use of opioids that results in the development of a dependency that adversely affects an individual's life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Opioid Use Disorder","conceptCode":"C157942","definition":"The use of opioids that results in the development of a dependency that adversely affects an individual's life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-1787-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-17A0-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Pedestrian Injury By Road Vehicle","valueDescription":"Pedestrian Injury By Road Vehicle","ValueMeaning":{"publicId":"7049966","version":"1","preferredName":"Pedestrian Injury By Road Vehicle","longName":"7049966","preferredDefinition":"An injury to a pedestrian sustained by a vehicle that travels on the road.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pedestrian Injury By Road Vehicle","conceptCode":"C157949","definition":"An injury to a pedestrian sustained by a vehicle that travels on the road.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-1761-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-177A-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Obstructed Labor","valueDescription":"Obstructed Labor","ValueMeaning":{"publicId":"7049970","version":"1","preferredName":"Obstructed Labor","longName":"7049970","preferredDefinition":"A physical barrier to the natural delivery of a baby.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obstructed Labor","conceptCode":"C157939","definition":"A physical barrier to the natural delivery of a baby.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-17AD-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-17C6-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Nutritional Deficiency","valueDescription":"Nutritional Deficiency","ValueMeaning":{"publicId":"7049972","version":"1","preferredName":"Nutritional Deficiency","longName":"7049972","preferredDefinition":"A deficiency of a necessary nutrient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nutritional Deficiency","conceptCode":"C157938","definition":"A deficiency of a necessary nutrient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-17D3-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-17EC-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Non-ischemic Stroke","valueDescription":"Non-ischemic Stroke","ValueMeaning":{"publicId":"7049974","version":"1","preferredName":"Non-ischemic Stroke","longName":"7049974","preferredDefinition":"Any stroke that is not related to an obstructed blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-ischemic Stroke","conceptCode":"C157937","definition":"Any stroke that is not related to an obstructed blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-17F9-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D60E73-1812-16B3-E053-F662850AECB5","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Non-communicable Disease","valueDescription":"Non-communicable Disease","ValueMeaning":{"publicId":"7049931","version":"1","preferredName":"Non-communicable Disease","longName":"7049931","preferredDefinition":"A disease that is not transmissible from one person to another.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Communicable Disorder","conceptCode":"C157935","definition":"A disorder that is not transmissible from one person to another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-0F65-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-0F7E-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Maternal Sepsis","valueDescription":"Maternal Sepsis","ValueMeaning":{"publicId":"7049934","version":"1","preferredName":"Maternal Sepsis","longName":"7049934","preferredDefinition":"A pathologic response to infection in a mother or pregnant woman.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maternal Sepsis","conceptCode":"C157917","definition":"A pathologic response to infection in a mother or pregnant woman.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-0F8B-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-0FA4-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Iodine Deficiency","valueDescription":"Iodine Deficiency","ValueMeaning":{"publicId":"7049936","version":"1","preferredName":"Iodine Deficiency","longName":"7049936","preferredDefinition":"A deficiency of iodine in the diet.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iodine Deficiency","conceptCode":"C157895","definition":"A deficiency of iodine in the diet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-0FB1-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-0FCA-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Intestinal Nematode Infection","valueDescription":"Intestinal Nematode Infection","ValueMeaning":{"publicId":"7049938","version":"1","preferredName":"Intestinal Nematode Infection","longName":"7049938","preferredDefinition":"An infection in the gastrointestinal tract by a nematode.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal Nematode Infection","conceptCode":"C157886","definition":"An infection in the gastrointestinal tract by a nematode.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-0FD7-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-0FF0-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Hypertensive Heart Disease","valueDescription":"Hypertensive Heart Disease","ValueMeaning":{"publicId":"7049940","version":"1","preferredName":"Hypertensive Heart Disease","longName":"7049940","preferredDefinition":"Heart conditions that are caused by high blood pressure, including coronary artery disease and heart failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertensive Heart Disease","conceptCode":"C157879","definition":"Heart conditions that are caused by high blood pressure, including coronary artery disease and heart failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-0FFD-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-1016-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"H influenze type B Pneumonia","valueDescription":"H influenze type B Pneumonia","ValueMeaning":{"publicId":"7049942","version":"1","preferredName":"H influenze type B Pneumonia","longName":"7049942","preferredDefinition":"Pneumonia that is attributed to the bacteria H influenze type B.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"H influenze type B Pneumonia","conceptCode":"C157868","definition":"Pneumonia that is attributed to the bacteria H influenze type B.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-1023-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-103C-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"H influenze type B Meningitis","valueDescription":"H influenze type B Meningitis","ValueMeaning":{"publicId":"7049944","version":"1","preferredName":"H influenze type B Meningitis","longName":"7049944","preferredDefinition":"Meningitis that is attributed to the bacteria H influenze type B.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"H influenze type B Meningitis","conceptCode":"C157867","definition":"Meningitis that is attributed to the bacteria H influenze type B.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D6940B-1049-2B52-E053-F662850A8837","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6940B-1062-2B52-E053-F662850A8837","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Rheumatic Heart Disease","valueDescription":"Rheumatic Heart Disease","ValueMeaning":{"publicId":"4394541","version":"1","preferredName":"Rheumatic Heart Disease","longName":"4394541","preferredDefinition":"An autoinflammatory condition following an infection with Group A Beta Hemolytic Streptococcus (GABHS), in which the heart is attacked by antibodies formed in reaction to a recent GABHS infection. Chief anatomic changes of the valve include leaflet thickening, commissural fusion, and shortening and thickening of the tendinous cords, all of which can result in valvular dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rheumatic Heart Disease","conceptCode":"C34882","definition":"An autoinflammatory condition following an infection with Group A Beta Hemolytic Streptococcus (GABHS), in which the heart is attacked by antibodies formed in reaction to a recent GABHS infection. Chief anatomic changes of the valve include leaflet thickening, commissural fusion, and shortening and thickening of the tendinous cords, all of which can result in valvular dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB4F6BC-38BB-C771-E040-BB89AD434694","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"KNABLEJ","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D6D222-464A-6946-E053-F662850A654C","beginDate":"2019-07-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Enterotoxigenic E coli Infection","valueDescription":"Enterotoxigenic E coli Infection","ValueMeaning":{"publicId":"7049925","version":"1","preferredName":"Enterotoxigenic E coli Infection","longName":"7049925","preferredDefinition":"A pathotype of Escherichia coli, which is a gram-negative bacteria that is transmitted through the fecal-oral route. It has an incubation period of 10-72 hours and a duration of 1-5 days. Symptoms may include acute, occasionally severe diarrhea without fever.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enterotoxigenic E coli Infection","conceptCode":"C157842","definition":"A pathotype of Escherichia coli, which is a gram-negative bacteria that is transmitted through the fecal-oral route. It has an incubation period of 10-72 hours and a duration of 1-5 days. Symptoms may include acute, occasionally severe diarrhea without fever.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D62BD8-BA57-787A-E053-F662850AF134","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D62BD8-BA70-787A-E053-F662850AF134","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Enteropathogenic E coli Infection","valueDescription":"Enteropathogenic E coli Infection","ValueMeaning":{"publicId":"7049927","version":"1","preferredName":"Enteropathogenic E coli Infection","longName":"7049927","preferredDefinition":"A pathotype of Escherichia coli, which is a gram-negative bacteria that is transmitted through the fecal-oral route. It has an incubation period of 9-12 hours and a duration of 12 days. Symptoms may include persistent severe acute diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enteropathogenic E coli Infection","conceptCode":"C157841","definition":"A pathotype of Escherichia coli, which is a gram-negative bacteria that is transmitted through the fecal-oral route. It has an incubation period of 9-12 hours and a duration of 12 days. Symptoms may include persistent severe acute diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D62BD8-BA7D-787A-E053-F662850AF134","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D62BD8-BA96-787A-E053-F662850AF134","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Chronic Kidney Disease due to Hypertension","valueDescription":"Chronic Kidney Disease due to Hypertension","ValueMeaning":{"publicId":"7049929","version":"1","preferredName":"Chronic Kidney Disease due to Hypertension","longName":"7049929","preferredDefinition":"Longstanding kidney disease as a complication of hypertension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease due to Hypertension","conceptCode":"C157814","definition":"Longstanding kidney disease as a complication of hypertension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D62BD8-BAA3-787A-E053-F662850AF134","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D62BD8-BABC-787A-E053-F662850AF134","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Maternal Hemorrhage","valueDescription":"Maternal Hemorrhage","ValueMeaning":{"publicId":"7049768","version":"1","preferredName":"Maternal Hemorrhage","longName":"7049768","preferredDefinition":"Uncontrolled bleeding from a pregnant or a woman who has recently given birth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maternal Hemorrhage","conceptCode":"C157916","definition":"Uncontrolled bleeding from a pregnant or a woman who has recently given birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D5AA59-B50A-788A-E053-F662850A156F","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D5AA59-B523-788A-E053-F662850A156F","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Pneumococcal Meningitis","valueDescription":"Pneumococcal Meningitis","ValueMeaning":{"publicId":"7049770","version":"1","preferredName":"Pneumococcal Meningitis","longName":"7049770","preferredDefinition":"Meningitis that is attributed to the bacteria Streptococcus pneumonia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumococcal Meningitis","conceptCode":"C157958","definition":"Meningitis that is attributed to the bacteria Streptococcus pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D5AA59-B530-788A-E053-F662850A156F","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D5AA59-B549-788A-E053-F662850A156F","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Rotaviral Enteritis","valueDescription":"Rotaviral Enteritis","ValueMeaning":{"publicId":"7049772","version":"1","preferredName":"Rotaviral Enteritis","longName":"7049772","preferredDefinition":"Enteritis attributed to the rotavirus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rotaviral Enteritis","conceptCode":"C157973","definition":"Enteritis attributed to the rotavirus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D5AA59-B556-788A-E053-F662850A156F","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D5AA59-B56F-788A-E053-F662850A156F","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"},{"value":"Intestinal Vascular Disorder","valueDescription":"Intestinal Vascular Disorder","ValueMeaning":{"publicId":"7050013","version":"1","preferredName":"Intestinal Vascular Disorder","longName":"7050013","preferredDefinition":"A non-neoplastic or neoplastic vascular disorder that affects the intestines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal Vascular Disorder","conceptCode":"C157888","definition":"A non-neoplastic or neoplastic vascular disorder that affects the intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D632AE-BC12-1475-E053-F662850A406A","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"96D632AE-BC2B-1475-E053-F662850A406A","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6780650","version":"1","preferredName":"CPTAC Medical Conditions Codelist Name","preferredDefinition":"Terminology used in support of the data collection efforts of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) with the focus on medical conditions.:The words or language units by which a thing is known.","longName":"C158035:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CPTAC Medical Conditions Codelist","conceptCode":"C158035","definition":"Terminology used in support of the data collection efforts of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) with the focus on medical conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B23F263-340F-0A59-E053-F662850A6261","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-12","modifiedBy":"ONEDATA","dateModified":"2019-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B23F263-3420-0A59-E053-F662850A6261","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-12","modifiedBy":"KNABLEJ","dateModified":"2019-11-10","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  6-12-19 CPTAC Medical History CRF; tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776734","version":"1","longName":"All Generic CRFs","context":"OCCPR"},{"publicId":"10000400","version":"1","longName":"Medical History","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Medical Condition","type":"Preferred Question Text","description":"Medical Condition","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B24CA40-2926-15C0-E053-F662850A5ED3","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-12","modifiedBy":"KNABLEJ","dateModified":"2019-11-10","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  11/8/19 jk upd 17 VM Defs; added 29 PVs; chg to Application status.  6-12-19 CPTAC Medical History CRF; tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}